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ABSTRACT 
Clostridium botulinum is an infamous pathogen that produces botulinum 
neurotoxin, the causative agent of potentially fatal, neuroparalytic disease in 
humans and animals called botulism. Despite decades of research, much 
remains unknown regarding neurotoxin gene location, toxigenesis, and 
physiology of C. botulinum. First, it is unclear whether mobile genetic 
elements can mediate transmission of type E neurotoxin gene. Second, the 
regulatory circuits of botulinum neurotoxin synthesis remain largely 
unknown. Third, the physiological mechanism of C. botulinum cold stress 
tolerance is of great importance in cold chain food processing and 
preservation, but remains poorly understood. The aim of this study was to 
investigate the location of the type E botulinum neurotoxin gene, identify the 
potential regulators of neurotoxin synthesis in Group I C. botulinum type A1 
strain ATCC 3502, and to characterize the regulon of the two-component 
signal transduction system (TCS) CBO0366/CBO0365 and its role in cold 
stress tolerance in C. botulinum ATCC 3502.  
A group of 36 C. botulinum type E strains was examined by pulsed-field 
gel electrophoresis and Southern hybridization with probes specific for type 
E neurotoxin gene (botE) and orfX1, a member of type E neurotoxin gene 
cluster. The results suggest that three C. botulinum strains encode botE and 
orfX1 in large plasmids of about 146 kb in size.  
In C. botulinum ATCC 3502, TCS CBO0787/CBO0786 was found to 
negatively regulate botulinum neurotoxin expression. Inactivation of 
cbo0787 encoding a sensor histidine kinase, or of cbo0786 encoding a 
response regulator, resulted in significantly elevated neurotoxin gene 
expression levels and increased neurotoxin production. Recombinant 
CBO0786 regulator was shown to bind to the conserved -10 site of the core 
promoters of the ntnh-botA and ha operons, which encode the toxin 
structural and accessory proteins. Increasing concentration of CBO0786 
inhibited BotR-directed transcription from the ntnh-botA and ha promoters, 
demonstrating direct transcriptional repression of the ntnh-botA and ha 
operons by CBO0786. 
CodY, a global regulator conserved in low-G+C Gram-positive bacteria, 
was shown to positively regulate the botulinum neurotoxin gene expression. 
Inactivation of codY resulted in decreased neurotoxin gene expression levels 
and reduced neurotoxin synthesis. Complementation of the codY mutation in 
trans rescued neurotoxin synthesis, and overexpression of codY in trans 
caused elevated neurotoxin production. Recombinant CodY was found to 
bind to probes possessing the neurotoxin gene promoters, but strongly 
interacted only with a 30-bp region in the promoter of ntnh-botA operon, 
suggesting regulation of the neurotoxin gene transcription through direct 
interaction. GTP enhanced the binding affinity of CodY to the ntnh-botA 
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promoter, suggesting CodY-mediated neurotoxin regulation is associated 
with nutritional status. 
A total of about 150 genes regulated by TCS CBO0366/CBO0365, were 
identified by DNA microarray. Inactivation of CBO0365 regulon genes 
encoding acetone-butanol-ethanol fermentation pathway, phosphate 
transport and arsenical resistance did not affect the growth of C. botulinum 
ATCC 3502 at 37 °C, but significantly impacted growth after a temperature 
downshift to 17 °C. These results suggest TCS CBO0366/CBO0365-regulated 
acetone-butanol-ethanol fermentation, phosphate transport and arsenical 
resistance play an important role in cold tolerance in C. botulinum ATCC 
3502.   
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1. INTRODUCTION 
As the most poisonous natural toxin, botulinum neurotoxin is typically 
encoded by a ~4,000-bp gene on chromosome or mobile genetic elements of 
Clostridium botulinum. Transmission of botulinum neurotoxin gene is 
evidenced by a role for horizontal transfer of neurotoxin gene carried on 
extra-chromosomal elements, such as plasmid or phage (Eklund et al., 1974; 
Marshall et al., 2010). However, it remains unclear whether type E 
neurotoxin gene is carried on extra-chromosomal elements. C. botulinum 
type E strain is highly prevalent in aquatic environments in the northern 
hemisphere. Investigation of type E neurotoxin gene location will shed new 
light on understanding the evolution and toxigenicity of type E C. botulinum. 
The method of toxigenesis intriguing for C. botulinum: on the one hand, it 
imparts extremely high toxicity to humans and animals, C. botulinum even 
synthesizes several non-toxic neurotoxin-associated proteins (NAPs) to 
shield and assist the neurotoxin in overcoming the barriers in host 
gastrointestinal tract (Gu and Jin, 2013). Neurotoxin synthesis appears to be 
an efficient survival strategy for C. botulinum to fulfil the neuron-specific 
attack, knock-down the host, and obtain nutrients. On the other hand, C. 
botulinum has very poor ability to compete with the entrenched microbiota 
in the gastrointestinal tract of adult humans and survive as vegetative cells. 
The majority of botulism cases are caused by the consumption of food 
containing neurotoxin (Lindström and Korkeala, 2006; Peck, 2006). 
Nutrient availability is an important determinant of neurotoxin synthesis in 
C. botulinum (Johnson and Bradshaw, 2001). Neurotoxin gene transcription 
is activated and enhanced when C. botulinum cells enter vegetative growth 
under nutrient-rich conditions, and is gradually switched off as the cells 
encounter nutrient limitation and enter stationary phase, followed by the 
adaptive processes such as neurotoxin release and sporulation (Bradshaw et 
al., 2004; Couesnon et al., 2006; Chen et al., 2008). Bacteria coordinating 
gene transcription in a developmental cycle-like mode is presumed to be an 
efficient way to increase fitness in a variable environment (Mekalanos, 1992).  
To better understand the toxigenesis of C. botulinum, it is necessary to 
extend the knowledge on the regulatory network of neurotoxin synthesis in C. 
botulinum. Identification of negative regulator of neurotoxin synthesis and 
regulator connecting neurotoxin synthesis to nutrient metabolism will have 
an important implication in developing novel strategies to prevent botulism.  
Some C. botulinum strains exhibit a remarkable ability to grow at low 
temperature, posing a serious hazard to modern food processing and 
preservation. The adaptive mechanism for cold tolerance of C. botulinum 
remains unclear. As an important bacterial signal transduction systems, two 
component systems (TCSs) are shown to respond to a change of environment 
temperature and promote the cold adaptation in several bacteria (Ullrich et 
Introduction 
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al., 1995; Aguilar et al., 2001; Hesami et al., 2011; Palonen et al., 2011). In C. 
botulinum ATCC 3502, TCS CBO0366/CBO0365 and TCS 
CBO2307/CBO2306 were identified to be essential for the cold stress 
tolerance (Lindström et al. 2012; Derman et al. 2013). Further unraveling the 
underlying molecular mechanism will provide new approaches to eliminate 
the food safety hazard posed by C. botulinum.   
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2. REVIEW OF THE LITERATURE 
2.1 Clostridium botulinum 
2.1.1 Classification 
Clostridium botulinum is a Gram-positive, low-G+C content, rod-shaped, 
spore-forming, anaerobic bacterium that produces botulinum neurotoxin 
(BoNT), the most potent natural toxin known to mankind. Botulinum 
neurotoxin blocks neurotransmission in cholinergic nerves (Schiavo et al., 
1992; Blasi et al., 1993) in humans and animals to cause botulism, a 
potentially fatal neuroparalytic disease. 
According to the antigenic properties of BoNTs, C. botulinum strains are 
classified into eight serotypes (A to H), with several subtypes therein (Smith 
et al., 2005; Chen et al., 2007; Hill et al., 2007; Dover et al., 2009; 
Macdonald et al., 2011; Barash and Arnon, 2014). Moreover, C. botulinum 
strains are divided into four distinct groups (I-IV) on the basis of the 
phylogenetic affiliation and physiological characteristics (Collins and East, 
1998). On the basis of strong proteolytic activity, group I is also called 
proteolytic C. botulinum which comprises all strains of serotype A and the 
proteolytic strains of serotypes B, F and recently identified serotype H. 
Clostridium sporogenes, a non-toxigenic species, is very closely related to 
group I C. botulinum strains. Group II consists of all strains of serotype E 
and the nonproteolytic strains of serotypes B and F. C. botulinum serotype A 
is found to be prevalent in the soils, while C. botulinum serotype E is 
commonly associated with the aquatic environments. Group I and group II C. 
botulinum are responsible for most botulism in humans. The group III 
strains produce neurotoxin serotypes C or D, which causes the majority of 
cases of botulism in animals. Group IV strains produce neurotoxin serotype 
G, which has not been found to be associated with any botulism in humans or 
animals and group IV C. botulinum is also known as Clostridium 
argentinense (Suen et al., 1988a). In addition to neurotoxigenic C. 
botulinum strains, some Clostridium butyricum and Clostridium baratii 
strains are also found to produce the botulinum neurotoxin type E and F, 
respectively (Suen et al., 1988b). 
2.1.2 Botulinum neurotoxin 
 
BoNT is formed in vegetative growing C. botulinum cells and released into 
culture via unknown mechanisms (Schantz and Johnson, 1992). A large 
amount of BoNT is released into the culture medium in stationary growth 
Review of the Literature 
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phase (Johnson and Bradshaw, 2001). BoNT is firstly synthesised as a 
precursor protein with a single polypeptide chain of ~ 150 kDa and post-
translationally nicked by protease into a 50 kDa light chain (LC) and a 100 
kDa heavy chain (HC), forming a disulphide-linked di-chain protein 
(Montecucco and Schiavo 1995). The action of BoNT to neuron is very 
specific and highly efficient (Bercsenyi et al., 2013; Rummel, 2013). The HC 
binds to the specific receptors on the neuronal surface and mediates 
translocation of LC across the endosomal membrane to the cytosol 
(Bercsenyi et el. 2013; Fischer, 2013), while the LC, a unique Zn2+-
metalloprotease, specifically cleaves three synaptic proteins (syntaxin, SNAP-
25 and synaptobrevin) within the the SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein receptor) complex (Binz, 2013; Ahnert-
Hilger et al., 2013), thereby blocking the neurotransmitter release and 
causing botulism.  
The primary form of botulism is foodborne botulism, an intoxication by 
consumption of BoNT-containing food (Lindström and Korkeala, 2006; 
Peck, 2006). It is estimated that consumption of only a few milligrams of 
BoNT-containing food is sufficient to cause illness and potentially death 
(Peck et al., 2011). The ingested BoNT will encounter the acidic stomach 
environment, protease degradation and a variety of host defence systems 
(Fujinaga et al., 2013; Gu and Jin, 2013). To survive the harsh 
gastrointestinal tract environment and across the intestinal epithelial barrier 
to enter the systemic circulation, BoNT is produced as a progenitor toxin 
complex (PTC) containing BoNT and several non-toxic neurotoxin-associated 
proteins (NAPs) (Sakaguchi 1982; Minton, 1995; Oguma et al. 1999). NAPs 
include a non-toxic non-hemagglutinin (NTNH) and three hemagglutinin 
proteins (HA-17, HA-33, and HA-70). BoNT-producing clostridia synthesize 
PTCs that vary from the combinations of BoNT and NTNH (M-PTC) to 
others combinations of HAs and M-PTC, with a total molecular weight 
ranging from 300 kDa to 900 kDa. PTCs exhibit much greater oral toxicity 
than uncomplexed BoNT, suggesting that NAPs play an important role in 
BoNT protection and/or absorption in the gastrointestinal tract (Ohishi et 
al., 1977; Sugii et al., 1977). NTNH is firstly shown to protect the BoNT from 
inactivation by low pH and protease. A further structure based study reveals 
that NTNH directly interacts with BoNT, forming an interlocked compact 
complex in a pH-dependent manner (Gu et al. 2012). Intriguingly, NTNH 
and BoNT show a remarkably similar structure despite the low sequence 
identity (~20%), implying that NTNH and BoNT might be evolved from a 
common ancestor by gene duplication. Although the role of HA proteins in 
the agglutination of red blood cells are recognized, HA proteins appear to 
mediate the absorption of PTC by interacting with oligosaccharides on 
intestinal epithelial cells (Matsumura et al., 2008; Amatsu et al., 2013). 
Recent studies suggest that HA proteins directly interact with E-cadherin and 
disrupt E-cadherin-mediated cell-to-cell adhesion, thus facilitating the BoNT 
across the intestinal epithelium via a paracellular transport. All three HA 
 15 
 
proteins are required for the full interaction with E-cadherin. However, the 
oligosaccharides-binding activity of HA proteins are not necessarily needed 
for the interaction with E-cadherin (Sugawara et al., 2010; Amatsu et al., 
2013).  
NTNH protein is the only NAP that is conserved in all neurotoxigenic C. 
botulinum strains. In C. botulinum type E, F and some type A strains, genes 
encoding HA proteins are replaced by orfx1-3 genes (Peck, 2009; Hill and 
Smith, 2013). The OrfX proteins are presumed to be NAPs that function 
similarly to HA proteins (Dineen et al., 2004). In C. botulinum type A2 strain 
Kyoto F, OrfX proteins have been detected in crude toxin preparations by 
Western blotting, however, the purified BoNT/A2 PTC was only composed of 
BoNT and NTNH (Lin et al., 2010). Similarly, the PTCs of BoNT/A1 and 
BoNT/B show the HA components as an extended arms-like conformation in 
electron microscopy (EM) micrographs. However, no arm-like conformation 
is observed in the BoNT/E progenitor complex (Benefield et al., 2013). The 
function of the OrfX proteins remains to be elucidated. 
2.2 Neurotoxin gene cluster 
2.2.1 Neurotoxin gene organization 
The genes encoding BoNT and NAPs are located together within a cluster 
(Figure 1). The organization of neurotoxin gene cluster varies in different 
types of BoNT-producing clostridia (Peck et al., 2011; Connan et al., 2013). 
The neurotoxin gene (bot) is located at one end of the cluster and is preceded 
by the ntnh gene. Both genes are encoded in the same direction and are the 
only genes found in all BoNT-producing clostridia.  
At the other end of the neurotoxin gene cluster, three hemagglutinin (HA) 
genes (ha33, ha17, and ha70) are encoded together in the direction opposite 
to that of ntnh-bot genes. In C. botulinum type E, F and some type A strains, 
the ha genes are missing and three orfX genes (orfX1, orfX2, and orfX3) are 
present in neurotoxin gene cluster. Interestingly, a gene (p47) encoding a 47 
kDa protein with unknown function is present immediately upstream of the 
ntnh gene along with the orfX genes.  Unlike the ntnh-bot genes, ha or orfX 
genes are not fully conserved in all BoNT-producing clostridia. The 
neurotoxin gene cluster of C. botulinum type G appears to include only ha17 
and ha70 (Bhandari et al., 1997), whereas the neurotoxin gene cluster of C. 
botulinum type A strain Mascarpone comprises only orfX1 and orfX2 
(Franciosa et al., 2006). In the neurotoxin gene cluster, a gene encoding an 
alternative sigma factor BotR is usually present between the ntnh-bot genes 
and ha or orfX genes. However, botR is absent from the neurotoxin gene 
cluster in C. botulinum type E (Kubota et al., 1998; Chen et al., 2007) and 
nonproteolytic type F (Dover et al., 2011). In C. botulinum type C and D, 
Review of the Literature 
16 
 
botR is located upstream of the ha genes at one end of neurotoxin gene 
cluster (Hauser et al., 1994; Nakajima et al., 1998). 
 
 
 
Figure 1 Diagram of botulinum neurotoxin gene cluster arrangements. 
2.2.2 Genomic localization and transfer of neurotoxin genes 
The neurotoxin gene cluster is encoded on chromosome or mobile genetic 
elements including phage and plasmid. The localization of the neurotoxin 
gene cluster displays is partly serotype-associated. In the early 1970s, the 
botC and botD clusters were found to be carried by bacteriophages (Iida et 
al., 1974). These findings were recently confirmed by genomic studies and 
the prophages carrying botC or botD existed in a large plasmid (Sakaguchi et 
al., 2005; Skarin et al., 2011).  The botG cluster is carried by a large plasmid 
(Zhou et al., 1995). The botA, botB and botF clusters were initially found in 
the bacterial chromosome, however, plasmid-borne toxin genes have recently 
been shown for subtypes A3 (Marshall et al., 2007), B1, B2, the non-
proteolytic type B (Franciosa et al., 2009; Hill et al., 2009; Umeda et al., 
ha70    ha17    ha33     botR               ntnh               botA1 Type A1  
(ATCC 3502, Hall A) 
      
Type A1 
(NCTC 2916) 
orfX3             orfX2   orfX1    botR      p47               ntnh                 botA1 
       
  orfX2    orfX1    botR     p47                ntnh                botA2 Type A2 
(Mascarpone) 
      
   ha70    ha17    ha33     botR              ntnh                botB Type B 
      
    orfX3        orfX2    orfX1        botR     p47                ntnh                botF1 Type F1 
       
orfX3           orfX2   orfX1      p47               ntnh                 botF6 Type F6 
(IBCA66-5436) 
      
orfX3          orfX2   orfX1      p47               ntnh                 botE Type E 
      
     ha70        ha17    botR               ntnh                botG Type G 
     
 botR              ha70    ha17    ha33             ntnh                botC, botD Type C,D 
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2009), and some bivalent subtypes, such as Ab, Ba and Bf (Smith et al., 
2007). Although an earlier study showed a possible plasmid-borne botE 
gene, more recent findings indicated a chromosome-encoded botE gene in 
neurotoxigenic C. butyricum (Hauser et al., 1992, Zhou et al., 1993, Wang et 
al., 2000, Hill et al., 2009, Franciosa et al., 2011). The two available C. 
botulinum type E genome sequences (NCBI) show chromosomal botE 
clusters. Whether type E neurotoxin genes in C. botulinum are carried by 
extra-chromosomal elements remains to be elucidated.  
It has been proposed that the neurotoxin gene cluster is subjected to 
horizontal gene transfer between different strains or groups of clostridia. 
Bacteriophages have been shown to carry either botC or botD are able to 
infect the nontoxigenic strains of C. botulinum group III (Eklund et al., 
1974). More recently, it was revealed that bot-encoding plasmids were able to 
conjugatively transfer from strains CDC-A3, 657 Ba4, and Eklund 17Bnp to a 
nontoxigenic mutant of strain 62A1 (Marshall et al., 2010), suggesting 
plasmid mediated horizontal transfer of the neurotoxin gene cluster from C. 
botulinum group II to group I strain. In addition, transposon mediated 
horizontal transfer of the neurotoxin gene cluster is also proposed by the 
presence of insertion sequence (IS) elements and transposon-associated 
proteins flanking the neurotoxin gene cluster (Hill et al., 2009). 
2.2.3 Transcriptional characteristics of neurotoxin genes 
Transcription of the neurotoxin gene cluster was first investigated in C. 
botulinum type C strain 468 (Hauser et al., 1994). Cotranscription of the 
ntnh-botC genes was confirmed by RT-PCR analysis, however, two 
transcription start sites were then mapped upstream of the ntnh and botC 
genes, respectively. These results suggest that botC is transcribed as 
monocistronic unit or bicistronic operon with the ntnh gene. In C. 
botulinum, type A strain NCTC 2916, a single 3.2 kb transcript comprising 
ha33, ha17, and ha70 genes, was detected by Northern blotting analysis and 
the transcription start site was mapped upstream of ha33 gene, suggesting 
that three ha genes are cotranscribed in an operon. A transcription start site 
was identified upstream of botR gene, however, the transcription level of 
botR gene was too low to be detected by Northern blot analysis in C. 
botulinum NCTC 2916 (Henderson et al., 1996). The characterization of the 
ntnh-bot transcription was challenged by a later finding that the NCTC 2916 
strain is bivalent and carries both the ntnh-botA1 genes and the ntnh-botB 
genes (Rodríguez Jovita et al., 1998). Nonetheless, the two transcripts (7.5 kb 
and 4 kb), identified by Northern blot, only correspond to the ntnh-botA 
gene and the botA gene, respectively. Two transcription start sites were then 
identified upstream of ntnh and botA by primer extension analysis 
(Henderson et al., 1996). These results suggest that botA is transcribed as 
either monocistronic mRNA or bicistronic mRNA with the upstream ntnh 
gene.  In C. botulinum type A1 strain 62A, a transcription start site was 
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mapped upstream of the botA gene by primer extension (Binz et al., 1990), 
however, this transcription start site differs from the finding in C. botulinum 
NCTC 2916 despite the same sequence in the region mapped between the two 
strains. In C. botulinum, Kyoto-F type A2 strain, a single 8.8 kb transcript 
encompassing the p47, ntnh and botA2 genes was identified by Northern blot 
analysis and a transcription start site was mapped upstream of the p47 gene, 
suggesting that the botA2 is transcribed in a tricistronic unit. Three orfX 
genes (orfX1, orfX2 and orfX3) were found to be cotranscribed in the other 
tricistronic operon by Northern blot analysis and the corresponding 
transcription start site was found upstream of the orfX1 gene. Despite the 
very low level detected, the transcription of botR gene was successfully 
characterized. A single 6 kb transcript with very low intensity was identified 
using a probe specific for botR by Northern blot analysis, suggesting that 
botR is likely cotranscribed with orfX1-3 genes. A transcription start site was 
mapped upstream of the botR gene (Dineen et al., 2004). 
Along with the identification of the transcription start site, the potential 
promoter regions of the neurotoxin gene cluster were also proposed. The 
predicted promoter regions of the ntnh-botA operon, the ha operon, and the 
orfX operon have been verified to contain the consensus -10 and -35 core 
promoter sequence of the neurotoxin gene in C. botulinum type A (Dineen et 
al., 2004).  
2.3 Transcriptional regulation of neurotoxin genes 
2.3.1 BotR-directed neurotoxin gene transcription  
The botR gene, encoding a 22 kDa protein, is conserved in all serotypes of C. 
botulinum except the type E and nonproteolytic type F. As the only gene 
within the neurotoxin gene cluster that encodes the protein having a helix-
turn-helix motif, BotR was hypothesized to be a regulator of neurotoxin gene 
expression (Hauser et al., 1995; Herderson et al., 1996). Investigation of this 
hypothesis led to a breakthrough in the study of neurotoxin regulation: The 
Popoff group showed that the transcription of botA, ntnh, ha33 and ha70 
were activated by overexpressing a plasmid-encoded botR in C. botulinum 
type A strain 62A. Altered BoNT/A and NAPs were also observed in 
overexpression experiments. Downregulation of botR by antisense mRNA 
expression resulted in decreased expression of botA, ntnh, ha33 and ha70, 
and reduced production of BoNT/A and NAPs in C. botulinum type A strain 
62A (Marvaud et al., 1998b). These results suggest that BotR positively 
regulates neurotoxin gene expression in C. botulinum type A. 
Further study showed that recombinant BotR can directly bind to the E. 
coli RNA polymerase core enzyme. The complex of E. coli RNA polymerase 
core enzyme and BotR was found to interact specifically with the predicted 
promoter regions of the ntnh-botA and ha operons. The in vitro transcripts 
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were synthesized from the DNA templates containing ntnh-botA and ha 
promoters only in the presence of both E. coli RNA polymerase core enzyme 
and BotR. These results demonstrate that BotR functions as an alternative 
sigma factor for RNA polymerase. BotR targeted promoters of the ntnh-botA 
and ha operons was further determined by DNase I footprinting analysis. 
The core promoter -10 (GTTATA) and -35 (TTTACA) sequences are identical 
in both operons (Raffestin et al., 2005).  
In C. botulinum, BotR proteins from strains with different toxin types 
share a high sequence identity (51-97%) (Dupuy et al., 2006). The -10 
(GTTATA) and -35 (TTTACA) sequences identified from C. botulinum type A, 
are also conserved in the corresponding promoter regions in other serotypes 
of C. botulinum that carry the botR gene. These findings strongly suggest that 
BotR-directed neurotoxin gene transcription is common in C. botulinum type 
A, B, C, D, proteolytic F, G and H. However, the botR gene is absent from the 
genome of C. botulinum type E and nonproteolytic F. Two genes homologous 
to C. perfringens uviAB were present upstream of type F7 neurotoxin gene 
cluster in nonproteolytic C. baratii strain IBCA03-0045. The uviA-like gene 
encodes a sigma factor that was found to direct RNA polymerase core enzyme 
binding to the putative promoters of p47 and orfX1 (Dover et al. 2014). 
Moreover, the similar uviA-like gene is found in the genome sequences of 
nonproteolytic C. botulinum type E strain Alaska and type F6 strain IBCA66-
5436. It remains to be elucidated whether the uviA-like gene is involved in 
the transcription of type E and nonproteolytic F neurotoxin genes.  
Apart from cotranscription with the ntnh gene, bot can be transcribed as 
monocistronic mRNA, and the corresponding transcription start site was 
mapped immediately upstream of bot gene (Henderson et al., 1996). 
However, no BotR-binding site was identified from this region and the 
complex of RNA polymerase core enzyme and BotR failed to generate any 
transcript from the related DNA template (Raffestin et al., 2005). Therefore, 
it appears that the alternative sigma factor BotR does not affect the 
monocistronic transcription of bot directly. Partial downregulation of botR 
by antisense mRNA caused a tremendous decrease in botA expression in C. 
botulinum type A strain 62A (Marvaud et al., 1998a). These could be proof 
that BotR-directed transcription of the ntnh-bot operon is the major form of 
bot transcription; However, it does not exclude the possibility that BotR 
might indirectly regulate bot monocistronic transcription. The physiological 
meaning of bot monocistronic transcription and the underlying transcription 
mode, remain to be elucidated.  
In clostridia, BotR is homologous to TetR of C. tetani, TcdR of C. difficile, 
and UviA of C. perfringens (Marvaud et al., 1998a; Marvaud et al., 1998b). 
TetR positively regulates tetanus toxin gene expression in C. tetani (Marvaud 
et al., 1998a). TcdR positively regulates the transcription of the genes (tcdA 
and tcdB) encoding toxin A and B, the major virulence factors of C. difficile 
(Mani and Dupuy, 2001). UviA positively regulates bacteriocin gene 
expression in C. perfringens (Dupuy et al., 2005). BotR, TetR, TcdR and 
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UviA are assigned in subgroup 5 of the sigma factor 70 family. The subregion 
4.2 in the four sigma factors is well-conserved, resulting that the promoters 
recognized by the four sigma factors have a highly conserved TTTACA 
hexanucleotide motif in the -35 region. In contrast, the subregion 2.4 is 
conserved only between BotR and TetR, but not with TcdR and UviA. As a 
consequence, a same -10 (GTTATA) sequence presenting in the promoters 
recognized by BotR and TetR, is markedly different from the -10 (CTCCTT 
and CTTTTT respectively) sequence of the promoters recognized by TcdR 
and UviA.  The difference in promoter -10 region is demonstrated to be 
directly relevant to the physiological function of the sigma factor. Using the 
β-glucuronidase gene fusion system, BotR and TetR were found to be 
functionally interchangeable in vivo. However, neither BotR nor TetR could 
direct the transcription from the promoters recognized by TcdR or UviA, and 
vice versa. An interesting β-glucuronidase gene fusion system was 
constructed with a hybrid ntnh-botA promoter by substituting the natural -10 
(GTTATA) sequence with the -10 (CTCCTT) sequence of tcdA promoter. BotR 
failed to direct the transcription from this hybrid promoter, but TcdR 
succeeded (Dupuy et al., 2006). These results reveal that the targeted 
promoter -10 region is the determinant of transcription specificity of BotR 
and its homologous sigma factors.  
2.3.2 Growth phase-dependent transcription pattern of neurotoxin 
genes 
The kinetics of neurotoxin gene transcription has been investigated in C. 
botulinum type A and E strains (Bradshaw et al., 2004; Couesnon et al., 
2006; Chen et al., 2008). Although different strains were cultured in 
different enriched media and exhibited different neurotoxin production, the 
neurotoxin gene expression pattern is surprisingly consistent. Transcription 
of the neurotoxin gene is primarily associated with the exponential growth 
phase of vegetative growing cells.  
In C. botulinum type A strains Hall and NCTC 2916, transcription of botA, 
ntnh, botR, ha33, ha17 and ha70 were measured at various time points by 
real-time quantitative reverse transcription PCR (qRT-PCR) (Couesnon et 
al., 2006). The expression pattern was similar for all tested genes in both 
strains. The expression of all genes was detected at a low level at the 
beginning of the exponential growth phase, followed by a rapid increase 
across the entire exponential growth phase. After peaking at the transition 
phase, the expression decreased to basal during the stationary phase. A 
similar expression pattern was also viewed by Northern blotting analysis of 
the transcripts of the ntnh-botA and ha operons in C. botulinum type A strain 
62A, Hall A-hyper and NCTC 2916 (Bradshaw et al., 2004). In C. botulinum 
type E strain HV, transcription of botE and p47 gene were also in the pattern 
similar to that of C. botulinum type A strains (Couesnon et al., 2006). These 
results are in line with the findings in C. botulinum type E strain CB11/1-1 
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(Chen et al., 2008). Moreover, transcription of orfX1, orfX2 and orfX3 genes 
also followed a similar expression pattern. These results suggest that a 
growth phase-associated regulation of neurotoxin gene cluster is well-
conserved in C. botulinum type A and E. 
In agreement with the transcription pattern of neurotoxin gene, 
neurotoxin production was also found to be increased rapidly in the 
exponential growth phase (Bradshaw et al., 2004; Couesnon et al., 2006; 
Chen et al., 2008). However, only a small proportion of synthesized 
neurotoxin was released into the culture medium by unknown mechanism. A 
large proportion of synthesized neurotoxin remained intracellular in the 
exponential growth phase, and then released into the culture medium in 
stationary growth phase. In contrast to the rapid decrease of neurotoxin gene 
transcription in stationary phase, the level of synthesized neurotoxin 
remained stable throughout the stationary phase.   
2.3.3 Agr-like quorum sensing systems 
Quorum sensing is a cell-cell signaling process in which bacteria monitor cell 
population density by producing and sensing extracellular chemicals called 
autoinducers (Miller and Bassler, 2001; Waters and Bassler 2005). When an 
autoinducer level reaches the critical threshold, each individual bacterial cell 
responds to the signal by regulating the gene expression synchronously in the 
community. Quorum sensing is used to regulate the development of a variety 
of bacterial lifestyles, such as bioluminescence, biofilm formation, antibiotic 
production, competence, sporulation and virulence. Acyl-homoserine 
lactones (AHLs) are a major class of autoinducer used by Gram-negative 
bacteria for quorum sensing, whereas small posttranslationally processed 
peptide signal molecules are primarily used as autoinducer in Gram-positive 
quorum-sensing systems. The AHL can freely diffuse across the bacterial 
membrane. Unlike that, peptide signals release and uptake must be mediated 
by specific oligopeptide transport systems. Peptide signal processing and 
modifications are often associated with the release. The reception and 
response of quorum sensing signals can be mediated by either one cognate 
DNA-binding regulator in cytoplasm or a two-component signal transduction 
system (TCS), typically consisting of a membrane-bound histidine kinase 
sensor and a cytoplasmic response regulator (Parker and Sperandio, 2008; 
Rutherford and Bassler 2012). 
The accessory gene regulator (Agr) quorum sensing system is firstly 
identified in Staphylococcus aureus and is paradigm of peptide quorum-
sensing system in Gram-positive bacteria (Novick and Geisinger, 2008). The 
Agr autoinducer is derived from a large precursor peptide, encoded by the 
agrD gene. The precursor peptide AgrD is processed to an octapeptide and is 
exported from the cell via the membrane-associated AgrB transporter. A 
transmembrane sensor kinase AgrC is the receptor of AgrD signal. The signal 
is transferred from AgrC to the cognate response regulator AgrA by 
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phosphorelay. The phosphorylated AgrA autoinduces the transcription of the 
agr operon and activates the expression of RNAIII, a regulatory RNA post-
transcriptionally activating the expression of numerous virulence factors. 
The Agr quorum sensing system is widely conserved among Gram-positive 
pathogens. A complete agrBDCA operon and an additional agrBD gene are 
evident in the genome of C. difficile hypervirulent strain 027 (Stabler et al., 
2009), however, their function remains to be elucidated. In C. perfringens 
type A strain, an agrBD homologue was identified to encode an Agr-like 
system that activates the expression of several virulence factors and is 
required for efficient sporulation (Ohtani et al., 2009; Li et al., 2011). 
Two copies of agrBD gene are conserved in the genome of most group I C. 
botulinum strains (Sebaihia et al., 2007). Surprisingly, C. botulinum type A3 
strain Loch Maree appears to carry three copies of agrBD gene. The function 
of agrBD homologues was investigated in C. botulinum type A1 strain ATCC 
3502 (Cooksley et al., 2010). Inactivation of agrD1 resulted in about 1000-
fold decreased spore count. In contrast, only a 70-fold decreased spore count 
was found in the culture of agrD2 mutant. The results of sporulation assay 
suggest that both Agr-like systems are involved in sporulation and Agr-1 
system seems to be the primary regulator. Botulinum neurotoxin production 
was observed to be decreased throughout the period from exponential 
growth phase to 24 h in both agrD1 and agrD2 mutants. In the late-
stationary growth phase (from 48h onwards), the neurotoxin production in 
the agrD1 mutant had then returned to wild-type (WT) levels. In contrast, 
the neurotoxin production in the agrD2 mutant was consistently about 3-
fold lower than that in WT strain. Therefore, Agr-1 system appears to delay 
the neurotoxin release to culture, while Agr-2 system appears to positively 
regulate botulinum neurotoxin production (Cooksley et al., 2010). 
Unexpectedly, the genes encoding two-component system agrCA is not 
conserved in either of the two agr loci in C. botulinum. The receptor of AgrD 
signal and potential regulator of neurotoxin production still remain to be 
defined.  
2.3.4 Two-component signal transduction systems 
Two-component signal transduction systems are a major signaling 
mechanism used by prokaryotes to sense and respond to diverse 
environmental cues (Krell et al., 2010). Genome analysis suggests that 
bacteria often contain dozens of TCSs (Barakat et al., 2009). Histidine kinase 
and response regulator genes encoding a typical TCS are frequently paired in 
the genome. Generally, histidine kinase contains an N-terminal input domain 
and a C-terminal transmitter domain. The input domain is often 
transmembrane and is responsible for the detection of a specific stimulus; 
either extracellular or intracellular. Upon stimulation, autophosphorylation 
occurs at a histidine residue in the transmitter domain. The high energy 
phosphoryl group is then transferred to a conserved aspartate residue on the 
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cognate response regulator receiver domain. A typical response regulator 
contains a DNA-binding output domain and acts as transcriptional regulator. 
The phosphorylation causes a conformation change in the output domain, 
enabling the response regulator finally to modulate the target gene 
expression (Figure 2) (Hoch, 2000; West and Stock, 2001). In addition to 
this classic mode of TCS organization and action, two genes of TCS have been 
implicated in evolution through gene fusion, fission and duplication, leading 
to the presence of a variety of alternative modes, such as a hybrid kinase 
containing transmitter and receiver domains, a TCS pathway consisting of 
multiple auxiliary proteins or connectors (Cock and Whitworth, 2007; 
Mitrophanov and Groisman, 2008). 
 
 
Figure 2 Schematic representation of a classic two-component signal transduction system. 
To survive in a particular niche in host organism, pathogenic bacteria 
employ their TCSs to monitor the environment and orchestrate their multiple 
lifestyles including virulence (Beier and Gross, 2006). P2CS database has 
classified TCS proteins from 13 completely sequenced genomes of C. 
botulinum, suggesting that C. botulinum contains 20~34 paired TCSs and 
15~55 orphan TCS proteins (http://www.p2cs.org/). In the model strain C. 
botulinum type A ATCC3502, the genes encoding of 29 paired TCSs, 7 
orphan histidine kinases and 14 orphan response regulators are found in the 
genome. All histidine kinases possess the prototypical structure except for a 
CheA-like kinase; 26 of total 43 response regulators (60.5%) have winged 
helix-turn-helix DNA-binding motif in the output domain. This proportion in 
C. botulinum is much higher than that in all bacterial phyla (30.1%) 
(Galperin, 2010). Interestingly, 4 response regulators possess the LytTR 
domain, a DNA-binding motif mainly consisting of β-sheets. The LytTR 
DNA-binding motif is found within the AlgR/AgrA/LytR family proteins that 
particularly regulate virulence factor production in pathogenic bacteria 
(Sidote et al., 2008). C. perfringens VirR, regulating the synthesis of several 
gas gangrene toxins, is also a member of the AlgR/AgrA/LytR family 
(Nikolskaya and Galperin, 2002; Ohtani et al., 2010). It remains unknown 
whether the AlgR/AgrA/LytR family response regulator in C. botulinum is 
involved in regulating neurotoxin production. 
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Using antisense mRNA strategy, a group of isogenic antisense strains of C. 
botulinum type A Hall were constructed in which each of 34 response 
regulator genes was individually knocked down (Connan et al., 2012).  Three 
antisense strains with knocked down of CLC_1093, CLC_1914 and 
CLC_0661 exhibited significant reduction in neurotoxin production in 
relation to C. botulinum type A Hall WT strain. Similarly, knocked down of 
the cognate senor kinase gene CLC_1094, CLC_1913 and CLC_0663 also 
caused decreased neurotoxin production. Transcription of neurotoxin cluster 
genes was analyzed in the three antisense strains with knocked down of 
response regulator genes. Transcription of botA, ntnh and ha34 genes were 
significantly decreased in the three antisense strains when compared to that 
in the WT strain. These results suggest that TCS CLC_1093/ CLC_1094, 
CLC_1914/ CLC_1913 and CLC_0661/CLC_0663 are involved in positive 
regulation of neurotoxin gene expression. Unexpectedly, botR transcription 
was not decreased, but a modest increase was noticed in the three antisense 
strains. This finding is not consistent with the function of botR that encodes 
an alternative sigma factor activating the transcription of neurotoxin genes. 
Whether and how the three TCSs regulate botR transcription is required to 
be elucidated; however, it is plausible that the three TCSs mediated 
regulation of neurotoxin production independent of BotR (Connan et al., 
2012).  
Two isogenic antisense strains with knocked down CLC_0410 and 
CLC_3294, respectively, exhibited several phenotypes distinct from the WT 
strain (Connan et al., 2012). An increased viscosity in culture medium was 
observed at the end of exponential growth phase. Reduced cell number was 
shown throughout the entire 24 h growth. Furthermore, incomplete cell-wall 
formation was observed by transmission electron microscopy, suggesting 
that the two TCSs CLC_0410/CLC_0411 and CLC_3294/CLC_3293 might be 
involved in the regulation of cell wall formation. Impaired cell wall might 
lead to the above growth phenotypes in the two isogenic antisense strains. 
Surprisingly, neurotoxin production was markedly decreased in the two 
isogenic antisense strains when compared to the WT strain, suggesting that 
TCSs CLC_0410/CLC_0411 and CLC_3294/CLC_3293 also play a role in 
regulation of neurotoxin production (Connan et al., 2012).  
CLC_0632 and CLC_1105, encoding two AlgR/AgrA/LytR family 
response regulators, were also examined using specific antisense mRNA. The 
isogenic antisense strain with knocked down CLC_0632 only showed delayed 
growth kinetic and neurotoxin production.  The isogenic antisense strain 
with knocked down CLC_1105, did not show any change in neurotoxin 
production in relation to the WT strain (Connan et al., 2012). Although 
CLC_0632 and CLC_1105 are homolog to virR, encoding the response 
regulator of gas gangrene toxins synthesis in C. perfringens, they do not 
appear to regulate the neurotoxin production. 
The investigation of TCSs function in C. botulinum type A Hall strain 
relied entirely on the strategy of antisense mRNA mediated knocked down of 
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TCS genes (Connan et al., 2012). The expression of targeted response 
regulator gene was only partially repressed using a knockdown strategy. This 
raises the possibility that partial repression for some response regulator 
genes might not be sufficient for inactivation of the gene function, especially 
when the function of response regulator depends not only on its cellular 
protein expression level, but also on its phosphorylation status (Wanner, 
1992; Gao and Stock, 2010). Therefore, further study of TCS function in 
neurotoxin production with gene knockout strategy is required.  
2.3.5 Nutrition signal dependent regulation of neurotoxin synthesis 
Early studies suggest that botulinum neurotoxin production is affected by the 
availability of certain carbon and nitrogen sources. The excess of arginine 
(20g/L) supplemented in a chemically-defined minimal medium led to a 
significant reduction of neurotoxin titers in C. botulinum Hall A and Okra B 
(Patterson-Curtis and Johnson, 1989). When a high level of glucose (50 g/L) 
was added in the minimal medium with 20 g/L of arginine, the botulinum 
neurotoxin titers were increased about 200-fold in C. botulinum Okra B. The 
addition of excess tryptophan (10-20 mM) to the minimal medium of C. 
botulinum type E also caused the decreased neurotoxin production (Leyer 
and Johnson, 1990). These findings suggest that botulinum neurotoxin 
synthesis is linked with nutrition-related metabolic pathways.  
Although the metabolic and regulatory networks of C. botulinum have not 
been studied, the global regulator CodY, acting as an important link between 
metabolism and virulence factor synthesis found in many low-G+C Gram-
positive pathogens (Sonenshein, 2005; Stenz et al., 2011), is also conserved 
in C. botulinum.  CodY is firstly identified in Bacillus subtilis and its function 
is similar to a transition state regulator. CodY governs the adaptation of the 
cell to the transition from exponential growth to stationary phase by 
repressing the transcription of a number of stationary-phase-genes during 
exponential growth in response to the intracellular level of GTP and 
branched chain amino acids (BCAAs). When cells enter stationary growth 
phase, the intracellular level of GTP and BCAAs are both decreased, resulting 
in the abrogation of CodY mediated repression of stationary-phase-genes 
(Ratnayake-Lecamwasam et al., 2001; Molle et al., 2003; Sonenshein, 2007). 
CodY regulon has been documented in several low-G+C Gram-positive 
bacteria. In those species, CodY represses the transcription of genes 
accounting for approximately 5% of the genome that generally function in the 
synthesis of several amino acids (BCAAs, histidine, and arginine) and 
transport of amino acids, peptides and sugars. However, CodY activates the 
pathways of carbon overflow metabolism and guanine nucleotide synthesis 
(Sonenshein, 2007). As a highly conserved global regulator, CodY not only 
shows the common role in metabolic regulation in other low-G+C Gram-
positive bacteria, but also affects numerous virulence phenotypes in some 
low-G+C Gram-positive pathogenic bacteria. CodY regulates virulence 
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mainly by interacting and/or interconnecting with other virulence-related 
regulatory systems or by unknown indirect manner in Streptococcus 
pyogenes (Malke et al., 2006; Malke and Ferretti, 2007), Listeria 
monocytogenes (Bennett et al., 2007; Lobel et al., 2012), Streptococcus 
pneumoniae (Hendriksen et al., 2008), Streptococcus mutans (Lemos et al., 
2008), S. aureus (Majerczyk et al., 2008; Pohl et al., 2009; Majerczyk et al., 
2010), Bacillus cereus (Hsueh et al., 2008; Frenzel et al., 2012) and Bacillus 
anthracis (van Schaik et al., 2009). Only a few virulence genes are 
demonstrated to be direct targets of CodY consistently in vivo and in vitro, 
such as pcpA encoding a choline-binding protein involved in the colonization 
of the nasopharynx in S. pneumonia (Hendriksen et al., 2008), hla encoding 
the haemolytic α-toxin and ica encoding the polysaccharide intercellular 
adhesin (PIA) protein in S. aureus (Majerczyk et al., 2008; Majerczyk et al., 
2010). 
The role of CodY in virulence regulation has also been documented in two 
clostridial pathogens. In C. perfringens type D strain CN3178, CodY 
positively regulates the epsilon toxin (ETX) gene expression. The direct 
interaction between CodY and the etx gene promoter was evidenced by 
electrophoretic mobility shift assay (EMSA) (Li et al., 2013). In C. difficile 
strain 630, CodY indirectly represses the transcription of genes encoding two 
main virulence factors, enterotoxin A (TcdA) and cytotoxin B (TcdB) through 
a direct repression of the transcription of tcdR that encodes an alternative 
sigma factor directing the transcription of tcdA and tcdB (Dineen et al., 
2007; Dineen et al., 2010). Whether CodY is involved in botulinum 
neurotoxin synthesis remains unclear. 
2.4 Cold tolerance of Clostridium botulinum 
Although group I, III and IV C. botulinum strains are mesophilic with an 
optimized growth temperature of around 37 °C, they are also able to grow at 
low temperature between 12 °C and 17 °C (Segner et al. 1971; Lynt et al. 1982; 
Hinderink et al. 2009; Lindström et al. 2014). Group II C. botulinum strains 
are psychrotrophic and their minimum growth-limiting temperature varies 
between 3 °C and 9 °C (Graham et al. 1997; Derman et al. 2011; Lindström et 
al. 2014).  
The molecular mechanism of cold tolerance in C. botulinum has been 
investigated in the model strain ATCC 3502 (Söderholm et al. 2011). The 
genome of C. botulinum ATCC 3502 carries three cold shock protein-coding 
genes (cspA, cspB and cspC). Expression of all csp genes were found to be 
significantly enhanced upon treatment of C. botulinum ATCC 3502 cells with 
a cold shock shift from 37 °C to 15 °C (Söderholm et al. 2011). However, the 
cspA mutant did not display a cold-sensitive phenotype. The cspC mutant 
showed a significantly reduced growth rate at 15 °C when compared to the 
WT. Only the cspB mutant was completely deficient in growth at 15 °C. These 
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results suggest that CspB is the major cold shock protein responsible for cold 
adaptation in C. botulinum ATCC 3502 (Söderholm et al. 2011).  
The role of TCS in cold response and adaptation has also been examined 
in C. botulinum ATCC 3502. TCS CBO0366/CBO0365 and TCS 
CBO2307/CBO2306 displayed similar expression pattern at 37 °C, with a 
decreased mRNA level throughout the exponential growth phase (Lindström 
et al. 2012; Derman et al. 2013).  Surprisingly, the two TCSs also showed a 
similar expression pattern upon cold shock. Expression of genes encoding 
TCS CBO0366/CBO0365 and TCS CBO2307/CBO2306 were significantly 
up-regulated when the culture temperature was down-shifted from 37 °C to 
15 °C (Lindström et al. 2012; Derman et al. 2013). In all TCSs of C. 
botulinum ATCC 3502, TCS CBO0366/CBO0365 exhibited the strongest 
induction upon temperature downshift (Dahlsten et al. 2014). Furthermore, 
disruption of each gene encoding both TCSs did not affect the growth at 
37 °C, but caused impaired growth at 15 °C (Lindström et al. 2012; Derman 
et al. 2013). These data support that TCS CBO0366/CBO0365 and TCS 
CBO2307/CBO2306 are involved in regulation of cold response and 
adaptation in C. botulinum ATCC 3502. Further characterization of the TCS 
regulon will offer new information about the cold adaptation mechanism in 
C. botulinum ATCC 3502. 
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3. AIMS OF THE STUDY  
The objectives of this study were to understand the genetic basis of 
neurotoxin gene localization, toxigenesis, and cold tolerance of C. botulinum.  
The specific aims were to: 
1. Investigate neurotoxin gene localization in C. botulinum type E strains 
(I) 
2. Characterize the roles of TCS CBO0787/CBO0786 and global regulator 
CodY in neurotoxin synthesis in C. botulinum type A1 strain ATCC 
3502 (II, III) 
3. Investigate the role of TCS CBO0366/CBO0365 in cold tolerance of C. 
botulinum type A1 strain ATCC 3502 (IV) 
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4. MATERIALS AND METHODS 
4.1 Bacterial strains, plasmids and culture conditions 
A collection of 36 C. botulinum type E strains isolated from aquatic-related 
environments was selected for evaluation of type E neurotoxin gene location 
(I). C. botulinum group I type A1 strain ATCC 3502 (Sebaihia et al., 2007) 
was used for genetic study (II-IV). C. botulinum was grown in anaerobic 
tryptone-peptone-glucose-yeast extract (TPGY) broth (5% tryptone, 0.5% 
peptone, 2% yeast extract [BactoTM, BD Biosciences, Sparks, USA], 0.4% 
glucose [VWR International, Leuven, Belgium], 0.1% sodium thioglycolate 
[Merck, Darmstadt, Germany]) at 37 °C (type A strain) or 30 °C (type E 
strain) in an anaerobic workstation with an atmosphere of 85% N2, 10% CO2 
and 5% H2 (MK III; Don Whitley Scientific Ltd., Shipley, UK). Escherichia 
coli was grown in Luria-Bertani (LB) medium at 37 °C. When needed, growth 
media were supplemented with 100 μg/ml ampicillin, 50 μg/ml kanamycin, 
25 μg/ml chloramphenicol, 250 μg/ml cycloserine, 15 μg/ml thiamphenicol 
2.5 μg/ml erythromycin, 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) 
or 0.2 % arabinose. 
4.2 Pulsed-field gel electrophoresis and Southern 
blotting analysis of C. botulinum type E strains (I) 
Experiments of pulsed-field gel electrophoresis (PFGE) followed by Southern 
hybridization were designed to investigate neurotoxin gene location in a 
group of 36 C. botulinum type E strains.  
 Agarose plugs containing genomic DNA of C. botulinum type E strains 
were prepared as described previously (Hielm et al., 1998) with slight 
modifications. Briefly, cell pellets from overnight TPGY cultures were 
collected and resuspended in PIV (10 mM Tris [pH 7.5], 1 M NaCl) 
containing 3% (vol/vol) formaldehyde solution and left on ice for 1 h. Cell 
suspensions were mixed with an equal amount of 2% (wt/vol) low-melting 
temperature InCert agarose (Lonza, Rockland, USA) and placed in syringe 
barrels. The gel plugs were lysed overnight in lysis solution (6 mM Tris [pH 
7.5], 1 M NaCl, 100 mM EDTA, 0.5% Brij 58, 0.2% deoxycholate, 0.5% 
sodium lauroyl sarcosine, 20 µg of RNase/ml, 1 mg of lysozyme/ml, 2 U of 
mutanolysin/ml) with gentle shaking at 37°C.  The isolation was completed 
with a 3-h wash in ESP (500 M EDTA [pH 8.0], 10% sodium N-
lauroylsarcosine, 1.8 mg of proteinase K/ml) at 50°C, followed by Pefabloc 
SC (Roche Applied Science, Mannheim, Germany) inactivation of proteinase 
K. To linearize potential large plasmid, single slices of gel plugs were treated 
with S1 nuclease (Promega, Madison, USA) at 37 °C for 45 min in S1 nuclease 
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buffer (Barton et al., 1995). The reaction was stopped by transferring the 
slices into ES buffer (500 mM EDTA [pH 8.0], 10 % sodium N-
lauroylsarcosine) on ice. All samples including genomic DNA or a low-range 
PFG marker (New England Biolabs, Ipswich, USA) were electrophoresed 
with the Gene Navigator system (GE Healthcare, Uppsala, Sweden) through 
1-% agarose gel in 0.5 TBE buffer. Pulse times ramped from 1 to 15 s over 18 
h at 6 V/cm.  Gels were stained with ethidium bromide and visualized using 
the AlphaImager 2000 (Alpha Innotech Corporation, San Leandro, USA). 
DIG-labeled hybridization probes targeted to 16S rrn, botE and orfX1 
were prepared by PCR-labeling. Primers used for probe generation are 
shown in Table 1. DNA samples were transferred from PFGE gels to 
positively charged nylon membranes (Roche Applied Science) using the 
VacuGene XL vacuum blotting system (GE Healthcare). After transfer, the 
membranes were consecutively hybridized, stripped and rehybridized with 
the 16S rrn, botE or orfX1 probe according to the Roche DIG Application 
Manual. Briefly, hybridizations were performed with a DIG-labeled probe in 
DIG Easy Hyb solutions (Roche Applied Science) at 42 °C overnight. The 
signals were detected using Anti-digoxigenin-AP conjugate and 
chemiluminescent substrate, CDP-Star (Roche Applied Science) and 
visualized on Hyperfilm ECL (GE Healthcare).  Membranes were hybridized 
initially with the 16S rrn probe. To rehybridize the membranes with the two 
other probes, the bound probes were stripped from the membranes by 
treatment with 0.2 M NaOH containing 0.1% sodium dodecyl sulfate at 37 °C 
for 30 min, followed by neutralization with 2 x SSC for 5 min. 
4.3 Genetic modification of C. botulinum 
4.3.1 Construction of mutants (II-IV) 
The insertional mutagenesis system ClosTron was used (Heap et al., 2007; 
Heap et al., 2010) to construct the mutants in C. botulinum ATCC 3502.  
For the mutation of cbo0787 and cbo0786 (II), the Ll.LtrB-derived 
introns were designed to target the cbo0786 sequence (between nucleotides 
267-268 in the sense strand) and the cbo0787 sequence (between nucleotides 
603-604 in the antisense strand), respectively, using the TargeTron 
algorithm (http://www.sigma-genosys.com/targetron/). The designed 
introns were generated by splice overlap extension (SOE) PCR using primers 
listed in Table 1 and cloned into pMTL007 forming the plasmid 
pMTL007::cbo0786 and pMTL007::cbo0787. 
 For the mutation of cbo0751 (arsC), cbo0753 (arsR), cbo1407 (bcd), 
cbo2436 (codY), cbo2525 (phoT), cbo2847 (ctfA), cbo3199 (bcd), and 
cbo3202 (crt), the target sites were identified using an online re-targeting 
algorithm (http://www.clostron.com/). The designed re-targeted 
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mutagenesis plasmids were ordered from DNA 2.0 (Menlo Park, USA) (III, 
IV). 
The re-targeted plasmids were individually transferred to C. botulinum 
ATCC3502 by conjugation from E. coli CA434 (Purdy et al., 2002). 
Successful transconjugants were screened on TPGY agar plates containing 
cycloserine (250 μg/ml) and thiamphenicol (15 μg/ml). For C. botulinum 
ATCC3502 carrying pMTL007 derived vectors, the intron expression was 
induced in 1 ml of anaerobic TPGY containing 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and thiamphenicol (7.5 µg/ml). For C. 
botulinum ATCC3502 carrying pMTL007C-E2 derived vectors, the IPTG 
induction was omitted. The subsequent integrands were selected by plating 
bacteria on TPGY agar supplemented with erythromycin (2.5 μg/ml) and 
cycloserine (250 μg/ml) and incubated for 16 h at 37°C in anaerobic 
conditions to select clones harboring the spliced erythromycin 
retrotransposition activated marker (ErmRAM), which indicates intron 
integration. 
To confirm the integration of the Ll.LtrB-derived intron in the desired 
site, PCR was performed using primers flanking the target site (Table 1). In 
addition, to confirm that only a single intron insertion occurred in each 
mutant, genomic DNA from the ATCC3502 WT strain and mutants, and the 
plasmid DNA of pMTL007 or pMTL007C-E2 were digested overnight with 
HindIII and analyzed by Southern blot probed with a DIG-labeled fragment 
derived from the Ll.LtrB intron sequence. 
4.3.2 Complementation and overexpression (I-II) 
pMTL82151, a plasmid containing pBP1 replicon from C. botulinum NCTC 
2916 (Heap et al., 2009), was used to construct the complementation and 
overexpression plasmids. 
For the complementation of cbo0786 (II), a 2441-bp fragment 
encompassing cbo0786, cbo0787, and the 5’ noncoding region including 
their putative promoter, was cloned into plasmid pMTL82151 to generate 
pMTL::cbo0787/0786. For the complementation of codY (III), a 1265-bp 
fragment containing codY and the 5’ noncoding region including the putative 
promoter was cloned into the pMTL82151 vector to create pMTL82151::codY. 
pMTL::cbo0787/0786, pMTL82151::codY or pMTL82151 was transferred to 
C. botulinum ATCC3502, the cbo0786 mutant or the codY mutant by 
conjugation to obtain the complementation strain of cbo0786-
pMTL::cbo0787/0786, codY-pMTL82151::codY, the overexpression strain 
WT-pMTL82151::codY and the control strains WT-pMTL82151, cbo0786-
pMTL82151 and codY-pMTL82151. 
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Table 1 Oligonucleotides.  
 
Primer Sequence(5’-3’)a 
ClosTron mutagenesis 
cbo0786-IBS AAAAAAGCTTATAATTATCCTTAAATGTCGTTTTAGTGCGCCCAGATAGGGTG 
cbo0786-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTTTTAGGTAACTTACCTTTCTTTGT 
cbo0786-EBS2 TGAACGCAAGTTTCTAATTTCGGTTACATTCCGATAGAGGAAAGTGTCT 
cbo0787-IBS AAAAAAGCTTATAATTATCCTTATATCTCATATTAGTGCGCCCAGATAGGGTG 
cbo0787-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCATATTATGTAACTTACCTTTCTTTGT 
cbo0787-EBS2 TGAACGCAAGTTTCTAATTTCGGTTAGATATCGATAGAGGAAAGTGTCT 
EBS Universal  CGAAATTAGAAACTTGCGTTCAGTAAAC 
PCR screening 
cbo0786-40-F GCCATTGGAGTGGAATATAC 
cbo0786-446-R GGCTCTATTATTATGTCCTTGG 
cbo0786-Spec-F ATATTTATGACTGCCTGTG 
cbo0787-429-F AGCGGAAGTGTTTACTAAAG 
cbo0787-948-R TTCTGCTGTCCAATCCATAT 
cbo0787-Spec-R 
codY-F 
codY-R 
ATTCCACTACTCCAGCCTC 
TTGAATGTGACGAAGTAAGG 
TTCTGTGCCATCTAACTCAT 
cbo0751M 254|255a R GGTCCTCTAATCCCCAATCC 
cbo0753M 196|197a R ATTTAATGAATAGTGACTCCATAATCC 
cbo1407M 428|429a R AAATTTAGGGGCCATGGAAG 
cbo2525M 122|123a R TCATCCTGACCACCAACATC 
cbo2847M 509|510a R TCCTCTCTCCAAAAGAGTCTCC 
cbo3199M 467|468a R ATCCTCTGTCTTGCCAATGC 
cbo3202M 167|168a R CGGCTTTTCCATGGTTTCTA 
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Primer Sequence(5’-3’)a 
 
Southern blots 
intron-693-F GCGTGCGACTCATAGAAT 
intron-1045-R TTGGATATTCACCGAACACT 
qRT-PCR 
botA-F CGCGAAATGGTTATGGCTCT 
botA-R GCCTGCACCTAAAAGAGGATTT 
ha33-F CATCTCCTGTAAGGCCGATACTAA 
botR-F AAATGACAATAGGGAGTTTCAAGA 
botR-R TGAAATTGCTCAAATCAACTTTTT 
16Srrn-F AGCGGTGAAATGCGTAGAGA 
16Srrn-R GGCACAGGGGGAGTTGATAC 
Complement of cbo0786 mutant 
cbo0786-F-NotI NNNNNNGCGGCCGCTAATTAAGTTTACAAGGATTCATAGCTCAC 
cbo0787-R-NheI 
codY-82151-F 
codY-82151-R 
NNNNNNGCTAGCGAATGAACCATCTTCACTATTAA 
NNNNNNGCGGCCGCGTGAAGAATGTGGAAGTTAC 
NNNNNNGCTAGCCTCCTTAGGTAGTATATCACAC 
Protein expression 
cbo0786-F-NdeI NNNNNNNNCATATGACAAAAATATTATTAGTAGAAGATGATATGGCT 
cbo0786-R-XhoI NNNNNNNNCTCGAGTTACTCACTCCACCTATAGCCTATTCC 
botR-F-NdeI                                            NNNNNNCATATGAATAAATTGTTTTTACAAATTAAAATGTT 
botR-R-XhoI                                            NNNNNNCTCGAGCTACATATTAATTAATTTTTTCAATATGGG 
codY-30-F                                                NNNNNGAATTCAGGAGGAATTAACCATGGGGGGTTCTCATCATCATCATCATCATGGTATGAGTTCATTACTAGATAA 
codY-30-R                                               NNNNNNGCATGCCTATTTTATCTTCTTTAATTCTTCTAAA 
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Primer Sequence(5’-3’)a 
  
cbo0365-F-NheI                                     CCCGCTAGCATGTCAGCAGAAAAAATCCTTATTG 
cbo0365-R-XhoI                                     CGCCTCGAGCTATTTTTCAACCTTATATCCAACTCC 
EMSA 
Pha33-F (5’-end labelled biotin)CGGCCTTACAGGAGATGGTA 
Pha33-R (5’-end labelled biotin)TTTCTTGAAACTCCCTATTGTCA 
Pntnh-botA-F (5’-end labelled biotin or IRD700)GGCTTTAGAGAGATTAGAACCCATA 
Pntnh-botA-R (5’-end labelled biotin or IRD700)CATTTTTATTATCTACCGGGGAAT 
Pcbo0364-150bp-F-5’ biotin (5’-end labelled biotin)AACAGGGCAAATATAAGGAAAGTG 
Pcbo0364-150bp-R TCAATTTAACTTCCCCCATAACC 
Pcbo0753-454bp-F-5’ biotin (5’-end labelled biotin)TCTTCAGCAACTTTTCTTATTTTATCA 
Pcbo0753-454bp-R TCTGATAGTGCTTTAATAATTTTTGC 
Pcbo0753-180bp-F-5’ biotin (5’-end labelled biotin)AGTTAATATTTTCATGTTCACATTT 
Pcbo0753-180bp-R CAAGCTCATTAATCTCCCTCCT 
Pcbo2525-223bp-F-5’ biotin (5’-end labelled biotin)TTTTTGGTGCCTATAACAAAAGC 
Pcbo2525-223bp-R TTCATTAATAAAAACCTCCGTTCA 
Pcbo3202-250bp-F-5’ biotin (5’-end labelled biotin)CAAAGTTTTATTTGATGGCAGT 
Pcbo3202-250bp-R TCCACTTAACCACCCCCTTA 
DNase I footprinting 
Pntnh-botA-F (5’-end labelled 6-FAM)GGCTTTAGAGAGATTAGAACCCATA 
Pntnh-botA-R (5’-end labelled HEX)CATTTTTATTATCTACCGGGGAAT 
Pha33-F (5’-end labelled 6-FAM)CGGCCTTACAGGAGATGGTA 
Pha33-R (5’-end labelled HEX)TTTCTTGAAACTCCCTATTGTCA 
In vitro run-off transcription  
ha33-SpeI                                                GCGGACTAGTAGTCTCCATCTTTCAAGGTA  
  
Table 1  Continued 
 
 
Primer Sequence(5’-3’)a 
ha33-PstI                                                 GCGGCTGCAGTTTACCACTACCCTTCCATA  
ntnh-PstI                                                  CGGCTGCAGGCTTTAGAGAGATTAGAACCC  
ntnh-SpeI                                                 GCGGACTAGTCTAGCTCTAACTACTACAAC  
 
a
, underlined sequence denotes a restriction enzyme site, sequence encoding the 6×His tag is marked in bold. 
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4.4 Transcriptional analysis 
4.4.1 RNA isolation and cDNA synthesis (II-IV) 
Total RNA from C. botulinum was isolated using RNeasy Mini Kit or RNeasy 
Midi Kit (Qiagen, Hilden, Germany). To remove the residual DNA, the RNA 
samples were treated sequentially with RNase-free DNase set (Qiagen) and 
the DNA-free Kit (Ambion Austin, USA) according to the manufacturers’ 
instructions. The RNA concentration was measured using the NanoDrop ND-
1000 spectrophotometer (Thermo Fisher Scientific, Waltham, USA). 
Integrity of the RNA was checked with the Agilent Technologies 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, USA).  
For qRT-PCR (II, III), cDNA samples were generated in duplicate from 
800 ng of RNA using the DyNAmoTM cDNA Synthesis Kit (Thermo Fisher 
Scientific). 
For microarray analysis (IV), cDNA probes were synthesized from 2 μg of 
RNA in a 30-μl reaction volume by incubation with random hexamers (Life 
Technologies, Carlsbad, USA) (0.2 μg/μl) and Superscript III RT (Life 
Technologies) for 3 h at 46°C. The reaction mixture contained 0.5 µM dATP, 
dTTP, and dGTP, 0.2 µM dCTP, 1.7 nmol of Cy-3 (two replicates of WT, one 
replicate of cbo0365 mutant) or Cy-5 (two replicates of cbo0365 mutant, one 
replicate of WT) labeled dCTP (GE Healthcare). Following inactivation, RNA 
degradation was performed by incubation at 70 °C with 0.5 mM EDTA and 
0.1 M NaOH for 15 min. The reaction was subsequently neutralized with 0.1 
M HCl. cDNA was purified using QIAquick PCR Purification Kit (Qiagen). 
4.4.2 Real-time quantitative reverse transcription-PCR (qRT-PCR) (II-
IV) 
qRT-PCR was performed with 16S ribosomal RNA (rrn) as the reference gene 
(Kirk et al., 2014), in the Rotor-Gene 3000 real-time thermal cycler 
(Qiagen). The reactions comprised of 1 x DyNAmo Flash SYBR Green I 
Master Mix or 1 x MaximaTM SYBR Green qPCR Master Mix (Thermo Fisher 
Scientific), 0.5 µM of each primer, and diluted cDNA template. In study II, 
PCR cycling was conducted with an initial 7 minutes at 95°C, 45 cycles of 
95°C for 10 seconds, 60°C for 20 seconds and 60°C for 30 seconds. In study 
III and IV, the cycling condition included 10 minutes at 95°C, followed by 40 
cycles of 95°C for 15 seconds and 60°C for 60 seconds. PCR efficiencies were 
determined for each primer pair based on a standard curve made from serial 
dilutions of pooled cDNA. Melting curve analysis was performed immediately 
after PCR to confirm specificity of the PCR amplification products. All 
reactions were performed with three biological replicates, each with two 
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technical replications. Target gene expression was normalized to the 16S rrn 
transcript level using a comparative Ct method (Pfaffl, 2001). 
4.4.3 DNA microarray analysis (IV) 
The 8x15K DNA microarrays including probes for 3641 genomic CDSs and 19 
CDSs of plasmid pBOT3502 in C. botulinum ATCC 3502, were custom-made 
by Agilent Technologies.  
Each hybridization reaction contained 300 ng of Cy3-labelled cDNA, 300 
ng of Cy5-labelled cDNA and 0.1 mg/ml salmon sperm DNA. The reaction 
was conducted at 65°C overnight with Hi-RPM GE Hybridization Kit (Agilent 
Technologies) and then washed with Gene Expression Wash Buffer Kit 
(Agilent Technologies). DNA microarrays were scanned using Axon GenePix 
Autoloader 4200 AL microarray laser scanner (Axon Instruments, CA, USA) 
and images were processed using GenePix Pro 6.0 software (Axon 
Instruments). 
Data analysis was performed using the R limma package (Smyth, 2005). 
For comparison between different arrays, signal intensities were converted 
into a logarithmic (log2) scale and normalized using the loess method (Smyth 
and Speed, 2003). Statistical analysis was performed to find differentially 
expressed genes between WT and cbo0365 mutant. Moderated t-test with 
empirical Bayes variance shrinkage was used for analysis of each probe on 
the array and the resulting p-values were converted into false discovery rate 
(FDR) values (Smyth, 2005). For each CDS, the probe with median 
unmodified p-value for the expression difference was chosen to represent the 
CDS. Of the representative CDSs, ones with FDR <0.05 were subsequently 
considered to have a significant difference in expression. 
4.5 Analysis of neurotoxin production (II, III) 
Botulinum neurotoxin in WT and mutant culture supernatants was 
determined using a commercial type A neurotoxin ELISA kit (Tetracore, 
Rockville, USA) according to the manufacturer’s instruction. The plates were 
read at 405 nm (Multiskan Ascent, Thermo Fisher Scientific). In study III, a 
linear standard curve was generated for each ELISA test using purified type 
A neurotoxin (kindly provided by Michel R. Popoff, Institute Pasteur, Paris, 
France) and all the coefficients of determination (R2) were above 0.997. 
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4.6 Protein-DNA interaction 
4.6.1 Protein expression and purification (II-IV) 
A histidine tagging strategy was used to yield the recombinant proteins of 
CBO0786, BotR, CodY, and CBO0365.  
cbo0786, botR, and cbo0365 were amplified by PCR and cloned 
individually into plasmid pET28b (Novagen, EMD Millipore, Billerica, USA), 
then individually transformed into E. coli Rosetta 2 (DE3) pLysS cells 
(Novagen) (II, IV). DNA sequence encoding 6 histidines was fused in frame 
upstream of the codY gene by PCR. The PCR product was cloned into 
plasmid pBAD30 (kindly provided by Bruno Dupuy, Institute Pasteur) and 
the resultant plasmid was transformed into E. coli strain LMG194 (Life 
Technologies) (III).  
Expression of CBO0786 and CBO0365 was induced with 1 mM IPTG at 37 
°C for 5 h (II, IV), while CodY expression was induced with 0.2 % arabinose 
at 37 °C for 8 h (III). Cells from a 200 to 500-ml culture were harvested, re-
suspended in 10 ml of lysis/binding buffer (500 mM NaCl, 20 mM imidazole, 
20 mM Tris-HCl, pH 7.9) and lysed by sonication. The lysate was centrifuged 
at 10 000 g for 15 min and filtered through a 0.45-µm filter. The lysate was 
loaded with 1 ml of Novagen His Bind affinity resin and allowed to bind for 
30 min at 4 °C. The resin was washed by 10 ml of lysis/binding buffer and 20 
ml of wash buffer (500 mM NaCl, 60 mM imidazole, 20 mM Tris-HCl, pH 
7.9). Bound protein was eluted by washing with 4 ml of elution buffer (500 
mM NaCl, 500 mM imidazole, 20 mM Tris-HCl, pH 7.9).  
BotR expression was induced with 1 mM IPTG overnight at 20 °C (II). 
Cells from a 500 ml culture were harvested and lysed by sonication in 
lysis/binding buffer. The insoluble cell debris was separated by 
centrifugation and dissolved in denaturing lysis/binding buffer with 6 M 
guanidine hydrochloride. After centrifugation and filtration, the denatured 
solubilized proteins were collected and loaded onto column containing Ni-
NTA affinity resin. The bound proteins were allowed to refold on column 
with a decreasing urea gradient (6 to 0 M) in lysis/binding buffer. Finally, the 
refolded BotR proteins were obtained by washing with elution buffer.  
Eluted fractions were examined by SDS-PAGE and fractions containing 
recombinant protein were pooled in the Novagen D-tube dialyzer and 
dialyzed against 1 l of dialysis buffer (300 mM NaCl, 20% glycerol, 50 mM 
Tris-HCl, pH 8.0) overnight at 4 °C.  Protein concentrations were determined 
by using the Bradford reagent (Bio-Rad, Hercules, USA) and BSA (Sigma-
Aldrich, St. Louis, USA) was used as a standard. 
4.6.2 Electrophoretic mobility shift assays (II-IV) 
Electrophoretic mobility shift assays (EMSAs) were carried out to test 
whether the DNA-binding regulator specifically binds to the promoters of 
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neurotoxin genes in vitro. DNA probes were labeled at the 5’-end by PCR 
with the biotin (II, IV) or the near-infrared fluorescent dye IRd 700 (LI-COR 
Biosciences, Lincoln, USA) (III). Labeled DNA probe was mixed with 
increasing amounts of CBO0786, CodY or CBO0365 protein in 20 µl 
reactions that contained 10 mM Tris-Cl (pH 7.8), 50 mM KCl, 1 mM DTT, 2.5 
% glycerol, 5 mM MgCl2 and 1 µg of poly (dI-dC) (Thermo Fisher Scientific). 
When required, effector of 2 mM GTP or 10 mM each of isoleucine, leucine 
and valine (BCAA) was added to the reaction. For competition assays, a 200-
fold molar excess of unlabeled probe was added. Binding reactions were 
allowed to proceed for 20 min at room temperature and then resolved on a 5 
% native polyacrylamide gel run in 0.5 x TBE at 4 °C for 1 h at 110 V. Gel 
shifts were visualized with a streptavidin-horseradish peroxidase followed by 
chemiluminescent detection (Thermo Fisher Scientific) (II, IV) or directly 
scanned using the LI-COR Odyssey infrared imaging system (III). 
4.6.3 DNase I footprinting (II, III) 
DNase I footprinting was performed in multiple replicates to identify the 
protein binding region in the promoters of neurotoxin genes using a modified 
method (Zianni et al., 2006). Each of Pntnh-botA and Pha33 probes was 5’-
end labeled by PCR with 6-FAM in the sense strand and the fluorescent dye 
HEX in the antisense strand. Binding reactions were performed as described 
for EMSA. After 20 min of incubation at room temperature, 0.002 to 0.2 
Kunitz unit of DNase I (Sigma-Aldrich) were added into the binding 
reactions and the DNase I digestion were performed for 5 min. Reactions 
were stopped by addition of 22 µl of 0.5 M EDTA and heated at 70 °C for 10 
min. The digested DNA fragments were purified with the QIAquick PCR 
Purification Kit (Qiagen) and separated on an Applied Biosystems DNA 
Analyzer with GeneScan ROX-500 or LIZ-500 internal size standard 
(Applied Biosystems, Foster City, USA).  The electropherograms were 
analyzed using the Peak Scanner software (Applied Biosystems).   
4.6.4 In vitro run-off transcription (II) 
In vitro transcription experiments were carried out to test if the response 
regulator CBO0786 inhibits BotR-directed transcription from the promoters 
of ntnh-botA and ha operons. The upstream region of the ha operon 
spanning the -191 to +185 sites relative to the transcription start, and the 
upstream region of the ntnh-botA operon spanning the -108 to +172 sites 
relative to the transcription start, were individually cloned into pBluescript II 
KS- (Stratagene, La Jolla, USA) and then digested by SpeI or PstI to create 
the run-off transcription templates. E. coli RNA polymerase (RNAP) core 
enzyme (Epicentre Biotechnologies, Madison, USA) was mixed with six-fold 
molar excess of purified BotR and preincubated at 37 °C for 30 min. The 
reaction mixture consisted of 0.5 U RNAP, 0 to 4 µM of recombinant 
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CBO0786, 15 nM of linearized plasmid DNA, 4 U of RNasin ribonuclease 
Inhibitor (Promega) and 10 µl of reaction buffer (40 mM Tris-HCl [pH 8.0], 
10 mM MgCl2, 50 mM KCl, 0.1 mg/ml BSA, 5 % glycerol). Run-off 
transcription was started by adding 200 µM each of ATP, GTP and CTP, 50 
µM of non-radioactive UTP and 2.5 µCi [-32P]-UTP (3000 Cimmol-1, Perkin-
Elmer, Waltham, USA). After 30 min incubation at 37 °C, the reaction was 
stopped by adding 10 µl of RNA loading buffer (95% formamide, 0.025% 
bromophenol blue, 0.025% xylene cyanol FF, and 5 mM EDTA), followed by 
heating for 10 min at 80 °C. Samples were loaded on 6% denaturing PAGE 
and visualized by autoradiography.  
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5. RESULTS 
5.1 Plasmid encoded neurotoxin genes in C. botulinum 
type E1 strains (I)  
PFGE analysis revealed that several extrachromosomal fragments ranging in 
size from 9 to 146 kb were presented in 11 strains including 250, CB11/1-1, 
K8, K15, K22, K23, K25, K28, K51, K101, and K119. To define these 
fragments, DNA of the PFGE gels was transferred to membranes and 
hybridized with digoxigenin-labeled 16S rrn probe. Hybridization signals 
with 16S rrn probe were observed for the large chromosomal DNA bands, but 
not for the smaller bands, suggesting that these smaller bands represented 
plasmids. These results suggest that 30 % of the tested C. botulinum type E 
strains harbor one or more plasmids ranging in size from 9 to 146 kb. Of the 
11 plasmid-containing strains, 8 strains were noted to be the producers of 
botulinum neurotoxin subtype E1. Toxin type of strain 250, K23, and K25 
remain unknown. 
To test whether any of the detected plasmids contained the neurotoxin 
genes, the same membranes were subsequently stripped and rehybridized 
with probes specific for botE and orfX1. Specific and distinct hybridization 
signals with botE probe, consistent with the hybridization signals obtained 
with the 16S rrn probe, were present on the position of the chromosomal 
DNA bands for 33 strains, suggesting that botE is located in a chromosomal 
locus in these strains. However, differing from the hybridization signals with 
the 16S rrn probe for strains CB11/1-1, K22, and K51, the botE probe 
hybridization signals were only observed in the plasmid bands of around 146 
kb in size. Further hybridization with orfX1 probe showed a similar result to 
the hybridization with the botE probe. These findings suggest that C. 
botulinum type E strains CB11/1-1, K22, and K51 carry their neurotoxin genes 
in large plasmids. 
5.2 Two-component signal transduction system (TCS) 
CBO0787/CBO0786 negatively regulates neurotoxin 
gene transcription (II) 
5.2.1 Inactivation of cbo0787 or cbo0786 genes resulted in increased 
neurotoxin gene expression and elevated neurotoxin synthesis 
Relative expression of botA encoding botulinum neurotoxin type A and ha33 
encoding one of the three haemagglutinins in WT and mutants were 
measured at mid-exponential, late exponential, and early stationary growth 
phases using qRT-PCR. Both botA and ha33 expression were significantly 
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induced in cbo0787 and cbo0786 mutants when compared to WT. The most 
prominent differences were mainly observed at early stationary growth 
phase. 
The relative amounts of botulinum neurotoxin in the culture of WT and 
mutants were compared using an enzyme-linked immunosorbent assay 
(ELISA). Neurotoxin production was found to be significantly enhanced (2.1 
to 3.7-fold higher OD405 readings, P < 0.05) in both the cbo0787 and 
cbo0786 mutant cultures relative to WT culture at late exponential and early 
stationary growth phases.  
Complementation of the cbo0786 mutation was conducted by introducing 
plasmid pMTL::cbo0787/0786, containing the TCS genes and their putative 
native promoter, into the cbo0786 mutant. The ELISA results showed that 
neurotoxin levels in the cultures of complemented strain cbo0786-
pMTL::cbo0787/0786 at early-stationary phase were restored to the WT-
pMTL82151 level.  
5.2.2 CBO0786 specifically interacts with the core promoter -10 region 
of both ntnh-botA and ha operons 
The interaction between the recombinant CBO0786 protein and DNA probes 
that encompassed the intergenic region between ha33 and botR containing 
the promoter of the ha operon (Pha33 probe), or the intergenic region 
between botR and ntnh containing the promoter of the ntnh-botA operon 
(Pntnh-botA probe) were examined by electrophoretic mobility shift assay 
(EMSA). CBO0786 caused a shift in the mobility of both probes. Specific 
binding was further confirmed by the disappearance of both protein-DNA 
complexes using competitor DNA of 200-fold excess of unlabeled probe. 
These results suggest that CBO0786 specifically recognizes and binds to the 
promoter regions of the ha and the ntnh-botA operons. 
To understand the DNA-binding specificity of CBO0786, the binding sites 
for CBO0786 to Pha33 and Pntnh-botA probes were determined using 
DNase I footprinting (Figure 3). With the Pha33 probe, the region protected 
by CBO0786 (-51 bp to -31 bp upstream of ha33 and -196 bp to -176 bp 
upstream of botR) was found in both strands (Figures 3A and 3B). In the 
botR coding strand of the Pha33 probe, the region protected by CBO0786 
was found from 51 bp to -31 bp upstream of ha33 (Figures 3A). The 
corresponding region in the ha33 coding strand showed a greater protection 
by CBO0786 than that in the botR coding strand, suggesting that the 
sequence (TATGTTATATGTTATATGTAA, Figure 3C) in the ha33 coding 
strand is the major CBO0786 binding site. Interestingly, the core promoter -
10 region (GTTATA) of the ha operon, recognized by the alternative sigma 
factor BotR (Raffestin et al., 2005), appeared as a direct repeat in the 
CBO0786 binding site, suggesting that CBO0786 represses transcription of 
the ha operon by binding to its core promoter. 
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In the Pntnh-botA probe, the site of CBO0786 protection was also 
identified to have a similar sequence to that observed with the Pha33 probe 
(Figures 3D and 3E). The same protection site was observed in both strands 
(GGCTATGTTATAT) (-120 bp to -108 bp upstream of ntnh, Figure 3F). The 
core promoter -10 region (GTTATA) of the ntnh-botA operon was also 
present in the binding region, but in one copy only. In accordance with the 
findings by EMSA, the binding affinity for CBO0786 to the ntnh-botA 
promoter also appeared lower than to the promoter of the ha operon in 
DNase I footprinting analysis. 
 
 
 
Figure 3 CBO0786 binds to the core promoter -10 region of the ha and ntnh-botA operons.  
DNase I footprinting analysis of 5’-6-FAM labeled sense strand (A, D) and 5’-HEX labeled 
antisense strand (B, E) of Pha33 probe (A, B) and Pntnh-botA probe (D, E). Comparison of 
DNase I digestion in the absence (blue peaks in A and D, green peaks in B and E) or with 10 µM 
of CBO0786 (red peaks). Protection regions are indicated by square brackets. Protection regions 
are underlined in sequencing electropherograms of Pha33 probe (C) and Pntnh-botA probe (F) in 
the sense strand. The consensus -10 regions of the ha and ntnh-botA promoters are indicated. 
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5.2.3 CBO0786 represses in vitro transcription from neurotoxin 
promoters  
To verify the direct repression role of CBO0786 in neurotoxin gene 
transcription, in vitro run-off transcription assays were carried out using 
RNAP reconstituted with E. coli RNAP core enzyme and the purified sigma 
factor BotR. DNA fragments containing the promoter of the ha or ntnh-botA 
operons were used as templates of in vitro transcription. As expected, RNAP 
core enzyme alone failed to activate the transcription of ha and ntnh-botA 
operons. When both RNAP core enzyme and BotR were added into the 
reaction,  the transcripts were generated from the promoters of ha or ntnh-
botA operons. Along with the presence of increased amount of recombinant 
CBO0786, both transcripts were effectively eliminated (Figure 4), suggesting 
CBO0786 directly represses the transcription from ha and ntnh-botA 
promoters in vitro. Taken together, these results indicate that CBO0786 
represses the transcription of neurotoxin gene cluster by binding to the 
consensus core promoter -10 region of ha and ntnh-botA operons. 
In vitro run-off transcription assays were also performed with DNA 
template containing the botR promoter. However, no clear transcript from 
botR promoter was visualized in the presence of RNAP core with BotR. 
Consistent with a previous finding (Raffestin et al., 2005), the result suggests 
that botR is not auto-transcribed in vitro. Whether CBO0786 directly 
represses the transcription of botR remains to be elucidated. 
 
 
 
Figure 4 CBO0786 represses transcription from ha and ntnh-botA promoters in vitro. Run-off 
transcription from ha33 and ntnh-botA promoter-containing templates was repressed in the 
presence of increasing concentration of CBO0786. Arrow indicates the run-off transcripts. 
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5.3 CodY positively regulates neurotoxin gene 
transcription (II) 
5.3.1 Disruption of codY caused decreased neurotoxin gene 
expression and reduced neurotoxin synthesis 
To examine whether the inactivation of codY affects the transcription of the 
neurotoxin gene, the relative expression of neurotoxin gene (botA) was 
compared between WT and the codY mutant at four time points from 
exponential growth phase to early stationary growth phase using qRT-PCR. 
Maximum transcript level of botA was observed at late exponential growth 
phase in both strains, suggesting that the tightly regulated transcription 
pattern of the neurotoxin gene cluster was maintained despite the codY 
mutation. The transcript levels of botA in the codY mutant were half of those 
observed in the WT, with the most prominent differences being observed at 9 
h of growth.  
Neurotoxin production in WT and the codY mutant were determined 
using ELISA. The amount of neurotoxin in culture supernatant of both WT 
and the codY mutant was increased from exponential growth phase to late 
stationary growth phase. The neurotoxin concentrations peaked at 60 μg/ml 
at 48 h of growth in the culture supernatant of WT, whereas the toxin 
concentrations in the culture supernatant of codY mutant reached only 30 
μg/ml at 48 h of growth. The reduced neurotoxin production in the codY 
mutant compared to WT was consistent with observations made at the 
transcriptional level.       
To verify the role of CodY in neurotoxin production, the codY mutation 
was complemented by introducing pMTL82151::codY, containing the codY 
coding sequence and its putative native promoter, into the codY mutant. A 
greater expression of CodY protein was found in the complementation strain 
codY-pMTL82151::codY than the vector control strain WT-pMTL82151 using 
Western blot analysis. No significant growth differences were found between 
codY-pMTL82151::codY, WT-pMTL82151 and codY-pMTL82151. Neurotoxin 
production in the three strains were compared by ELISA. The neurotoxin 
concentrations in the culture supernatant of the codY-pMTL82151::codY was 
found to be 3 and 2-fold higher levels than in the codY-pMTL82151 at 48 and 
96 h of growth, respectively, suggesting that complementation of the codY 
mutation rescued neurotoxin production. Moreover, the complementation 
strain codY-pMTL82151::codY produced a significantly higher amount of 
neurotoxin than the vector control strain WT-pMTL82151, which might have 
resulted from a relatively high copy number of pMTL82151::codY in the codY 
mutant leading to induced expression of the plasmid-encoded codY. To test 
this hypothesis, a codY overexpression strain was constructed by introducing 
pMTL82151::codY into WT, generating WT-pMTL82151::codY. No significant 
growth differences were observed between the overexpression strain WT-
pMTL82151::codY, the complementation strain codY-pMTL82151::codY,  and 
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the vector control strains WT-pMTL82151 and codY-pMTL82151. Similar to 
the observations in complementation, Western blot also showed that WT-
pMTL82151::codY expressed CodY protein at a considerably higher level than 
the WT-pMTL82151 control. Expectedly, the neurotoxin concentration in the 
culture supernatant of WT-pMTL82151::codY was also significantly higher 
than that in the WT-pMTL82151 supernatant. 
5.3.2 CodY specifically interacts with a 30-bp region in the promoter 
of ntnh-botA operon 
To investigate whether CodY directly regulates neurotoxin gene 
transcription, EMSA was performed to examine the binding affinity for CodY 
to the promoter of the ntnh-botA operon (Pntnh-botA probe). The presence 
of an increasing amount of CodY caused a shift in the mobility of Pntnh-botA 
probe, and the specific nature of binding was further confirmed by 
disappearance of the protein-DNA complex using competition with a 200-
fold excess of unlabeled Pntnh-botA probe.  
GTP and BCAAs were indicated to be CodY ligands and enhance the 
binding affinity for CodY to its target gene promoters in some low-G+C 
Gram-positive bacteria (Dineen et al., 2007; Shivers and Sonenshein, 2004; 
Handke et al., 2008; Majerczyk et al., 2010; Château et al., 2013). To test if 
CodY of C. botulinum responded to GTP and BCAAs, the EMSA procedure 
was repeated with the addition of 2 mM GTP or 10 mM BCAAs in the binding 
reactions. The binding affinity for CodY to Pntnh-botA probe was increased 
in the presence of 2 mM GTP.  In contrast, the combination of CodY and 10 
mM BCAAs did not cause any increased binding affinity to Pntnh-botA 
probe. The results suggest that CodY recognizes and binds to the promoter 
region of the ntnh-botA operon in vitro. GTP, but not BCAAs, may enhance 
the binding affinity of CodY to Pntnh-botA, supporting the hypothesis that 
CodY acts in response to intracellular levels of GTP in C. botulinum. 
To further characterize the DNA-binding specificity of CodY, DNase I 
footprinting analysis was performed to identify the CodY-binding site using 
fluorescently end-labeled Pntnh-botA probe. In both strands of the Pntnh-
botA sequence, a 30-bp region (-108 bp to -79 bp upstream of ntnh), 
encompassing the transcriptional start site of the ntnh-botA operon 
(Raffestin et al., 2005), was found to be protected by CodY from DNase I 
digestion (Figure 5A and 5B).  
The 15-bp AT-rich palindromic sequence AATTTTCWGAAAATT was 
identified as a consensus CodY-binding motif in Lactococcus lactis (den 
Hengst et al., 2005; Guédon et al., 2005) and B. subtilis (Belitsky and 
Sonenshein, 2008), and also resembled the CodY-binding sites in S. aureus 
(Majerczyk et al., 2010) and C. difficile (Dineen et al., 2010). Analysis of the 
promoter DNA sequence of ntnh-botA operon suggested that a putative 
CodY-binding motif, AATaTaCTGAAAAaT, with three mismatches to the 
consensus CodY-binding motif, was present in the 30-bp region of Pntnh-
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botA. Another putative CodY-binding motif, tATTTTtAaAAAATT, similarly 
containing three mismatches, was present in an AT-rich region neighboring 
the core promoter -35 region of the ntnh-botA operon (Figure 5C). 
Immediately upstream of this 30-bp region, the core promoter of the ntnh-
botA operon (Raffestin et al., 2005) and the AT-rich region showed relatively 
weak interaction with CodY in the sense strand of the Pntnh-botA sequence 
(Figure 5A). In contrast, the corresponding region did not show any 
interaction with CodY in the antisense strand of the Pntnh-botA sequence. 
The results suggest that CodY mainly interacts with a 30-bp region in the 
promoter region of the ntnh-botA operon. 
 
 
 
Figure 5 DNase I footprinting assay for binding of CodY to promoter of ntnh-botA operon. 
Fragment analysis of 5’-6-FAM labeled sense strand (A) and 5’-HEX labeled antisense strand (B) 
of Pntnh-botA probe show DNase I digestion in the absence of (blue peaks in A and green peaks 
in B) or with 5 µM of CodY (red peaks). Protection region is indicated by square brackets in 
electropherograms and the corresponding sequence is underlined in the Pntnh-botA sequence 
(C). Two putative CodY-binding motifs are indicated in bold letters. The core promoter -10 and -
35 regions, transcriptional start site, and translational start site of the ntnh-botA operon are 
shown in red. 
5.4 Two-component signal transduction system (TCS) 
CBO0366/CBO0365 regulon genes involved in cold 
tolerance (IV)  
To characterize the regulon of TCS CBO0366/CBO0365, the transcriptomes 
of WT and cbo0365 mutant strains during growth at 37 °C and 1 h after a 
temperature downshift to 15 °C were compared using DNA microarrays. A 
total of about 150 genes were found to be significantly up- or down-regulated 
(median log2 ratios < -2.0 or > 2.0, false discovery rate [FDR] < 0.05) in the 
cbo0365 mutant when compared to WT strain both at 37 °C and 15 °C, 
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suggesting that the putative CBO0365 regulon was basically not affected by 
temperature downshift. Of the CBO0365 regulon, cbo0753-cbo0756 
encoding arsenical resistance genes and cbo2521-cbo2525 encoding 
phosphate binding and transport genes were shown to be up-regulated, while 
cbo3197-cbo3199 and cbo3200-cbo3202 related to acetone-butanol-ethanol 
(ABE) fermentation were found to be down-regulated in the cbo0365 mutant 
when compared to WT strain. The binding ability of recombinant CBO0365 
to the putative promoters of cbo0753 (arsR) encoding arsenical resistance 
operon repressor, cbo2525 (phoT) encoding phosphate ABC transporter 
substrate binding protein, and cbo3202 (crt) encoding 3-hydroxybutyryl-
CoA dehydratase was examined by EMSA. In vitro phosphorylated CBO0365 
was found to specifically bind to the promoter region of cbo0753, cbo2525, 
and cbo3202, suggesting TCS CBO0366/CBO0365 may directly regulate the 
transcription of cbo0753, cbo2525, and cbo3202. 
To investigate whether ABE fermentation, arsenical resistance, and 
phosphate transport is relevant to cold tolerance in C. botulinum, mutants of 
cbo0751 (arsC) encoding arsenate reductase, cbo0753, cbo2525, cbo1407 
(bdh) encoding NADH-dependent butanol dehydrogenase, cbo2847 (ctfA) 
encoding butyrate-acetoacetate CoA-transferase subunit A, cbo3199 (bcd) 
encoding butyryl-CoA dehydrogenase, and cbo3202 were individually 
constructed using ClosTron mutagenesis system. The cbo0751, cbo1407, and 
cbo2847 mutants exhibited significantly reduced growth at 17 °C. 
Inactivation of cbo0753, cbo2525, and cbo3202, resulted in absolute growth 
defect at 17 °C. A mild decrease in the growth rate of the cbo3199 mutant was 
also observed at 17 °C. In contrast, none of the mutants showed significant 
difference in growth at 37 °C in relation to the WT strain. These results 
suggest that TCS CBO0366/CBO0365-regulated ABE fermentation, arsenical 
resistance and phosphate transport play important roles in cold tolerance of 
C. botulinum. 
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6. DISCUSSION 
6.1 Plasmid encoded neurotoxin genes in C. botulinum 
type E1 strains (I) 
C. botulinum strains CB11/1-1, K51, and K22 were found to encode a plasmid-
borne botE. The three strains were isolated from fish in the 1990’s in 
Finland. CB11/1-1 was the cause of a food botulism case in Finland in 1999 
(Lindström et al., 2004) and epidemiologically irrelevant to K51 and K22. 
Previous genotyping studies revealed that CB11/1-1 and K51 were together in 
a cluster and were genetically distant from K22 (Hyytiä et al., 1999; Keto-
Timonen et al., 2005; Derman et al., 2011), suggesting that the botE-
encoding plasmids are carried by C. botulinum  strains representing at least 
two distinct genetic backgrounds. CB11/1-1 was found to share a high 
similarity with the nontoxigenic C. botulinum strains H61 (96%) and P565 
(88%) in our amplified fragment length polymorphism (AFLP) analysis (data 
not shown), implying a possible lateral transfer of the botE-encoding plasmid 
between toxigenic and nontoxigenic strains. AFLP analysis also showed that 
K51 had a close genetic relatedness (higher than 85% similarity) to the 
chromosomal botE-carrying strains K23 and K28 (Keto-Timonen et al., 
2005). In this study, K23 and K28 were found to harbor plasmids that are 
smaller than botE-encoding plasmid of K51 in size. It is unknown if the 
plasmids detected in K23 and K28 showed similarity to botE-encoding 
plasmid of K51 or if K23 and K28 obtained their chromosomal neurotoxin 
genes as a result of plasmid transfer and further integration into their 
chromosome. Further comparative genome study will provide more evidence 
to understand the role of botE-encoding plasmid in the evolution of C. 
botulinum. 
Mobility of plasmids is frequently mediated by a conjugation mechanism 
(Smillie et al., 2010). A recent study revealed that bot-encoding plasmids 
were able to conjugatively transfer from strains CDC-A3, 657 Ba4, and 
Eklund 17Bnp to a nontoxigenic mutant of strain 62A1 (Marshall et al., 
2010). Further studies are required to evaluate if the botE-encoding plasmids 
are able to conjugatively transfer to other C. botulinum or C. butyricum 
strains.  Although a previous study on 13 C. butyricum isolates showed all 
strains to carry their botE on chromosome, the PFGE image indicated that 
four isolates, including those from two infant botulism cases, might harbor 
plasmids ranging in size from 120 to 170 kb (Wang et al., 2000). Further 
study of potential large plasmid in C. butyricum will offer an important clue 
about the possibility of plasmid-mediated lateral transfer of botE between C. 
botulinum and C. butyricum. 
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6.2 Two-component signal transduction system (TCS) 
CBO0787/CBO0786 negatively regulates neurotoxin 
gene transcription (II)  
This study focused on neurotoxin regulation in the most well-
characterized group I C. botulinum type A1 strain. It is necessary to 
investigate whether the CBO0787/CBO0786 homologs in strains of other 
subtypes play a repression role in neurotoxin gene transcription. While the 
cbo0787/cbo0786 locus is found at an 11-kb distance from the neurotoxin 
gene cluster (cbo0801-cbo0806) in C. botulinum ATCC 3502, a TCS showing 
a strikingly high (> 95 %) amino acid identity to CBO0787/CBO0786 is 
similarly encoded by loci near the neurotoxin gene cluster in the genomes of 
type A2 strain Kyoto (3.6 kb distance), type A5 strain H04402 065 (12 kb), 
and type F strain Langeland (24 kb). This TCS, therefore, is an interesting 
candidate for a universal neurotoxin repressor in Group I C. botulinum.  
The relative expression of neurotoxin gene in the cbo0786 mutant was 
significantly higher than those of the WT at logarithmic growth phase, this 
difference was less striking at early stationary growth phase. In contrast, the 
relative expression of neurotoxin gene in the cbo0787 mutant was drastically 
increased at both logarithmic growth phase and early stationary growth 
phase. These results imply that CBO0787 might be a central sensor of the 
signals responsible for repression of neurotoxin gene transcription and, apart 
from interacting with CBO0786, it might also activate other DNA-binding 
regulators. The sensor domain of CBO0787 is predicted to contain an 
extracellular loop consisting of 79 amino acid residues and is flanked by two 
transmembrane domains, indicating that an extracytoplasmic signal most 
likely triggers CBO0787. 
The environmental signal triggering CBO0787 and the phosphotransfer 
process between CBO0787 and CBO0786 remain to be elucidated. All 
biochemical data suggested that in vitro phosphorylation was not required 
for the DNA-binding activity of CBO0786 to the neurotoxin gene promoter, 
which is in line with reports on some other TCS response regulators showing 
similar DNA-binding properties regardless of in vitro phosphorylation state 
(Gao and Stock, 2009). However, in vivo phosphorylation of response 
regulator might lead to conformational changes that fine-tune its DNA 
binding affinity (He and Zahrt, 2005; Sinha et al., 2008; Mittal and Kroos, 
2009;). Identification of the signal triggering CBO0787 will be an important 
future task for optimization of in vivo conditions to effectively detect 
phosphorylation signal-triggered phenotypes.  
Protein-DNA interaction data suggested that CBO0786 recognized and 
interacted with the consensus -10 region (GTTATA) of the ha and ntnh-botA 
operon promoters. Previous results have shown that the -10 region is 
specifically recognized by the alternative sigma factor BotR (Raffestin et al., 
2005), which is critically required for neurotoxin gene transcription 
(Marvaud et al., 1998a) but does not appear to be an autoregulator of its own 
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transcription (Raffestin et al., 2005). While the -35 site (TTTACA) of the ha 
and ntnh-botA core promoters is also found upstream of botR, the -10 site of 
botR promoter is different (TTCGTA) (Raffestin et al., 2005). Moreover, no 
additional CBO0786 binding site downstream of the botR promoter was 
identified in vitro or in silico. Thus it is plausible that CBO0786 does not 
repress botR transcription. 
BotR homologues in other pathogenic Clostridia, such as TetR controlling 
tetanus neurotoxin in Clostridium tetani (Marvaud et al., 1998b), TcdR 
controlling toxins A and B in Clostridium difficile (Mani and Dupuy, 2001), 
and UviA controlling bacteriocins in Clostridium perfringens (Dupuy et al., 
2005), all recognize the same -35 sequence as BotR (Raffestin et al., 2005). 
However, only TetR recognizes the same -10 box (GTTATA) as BotR 
(Raffestin et al., 2005). TCS CTC01420/CTC01421 in C. tetani E88 is highly 
homologous to TCS CBO0787/CBO786 in C. tetani, with the response 
regulator CTC01421 showing 75 % amino acid similarity to CBO0786. TCS 
CTC01420/CTC01421 might play a repression role in tetanus neurotoxin 
transcription.  
6.3 CodY positively regulates neurotoxin gene 
transcription (III) 
Global regulator CodY was found to positively regulate botulinum neurotoxin 
expression in C. botulinum Group I type A1 strain ATCC 3502. The direct 
regulation was supported by CodY interacting with a 30-bp region 
encompassing the transcriptional start site in the promoter region of the 
ntnh-botA operon. The DNA-binding domain at the C-terminal of CodY is 
highly conserved in low-G+C Gram-positive bacteria (Joseph et al., 2005; 
Levdikov et al., 2006; Villapakkam et al., 2009), supplying the CodY 
homologs with a general property in the recognition of target DNA. Analysis 
of the DNA sequence in the 30-bp region revealed the presence of a putative 
CodY-binding motif, AATaTaCTGAAAAaT, with three mismatches to the 
consensus CodY-binding motif AATTTTCWGAAAATT (den Hengst et al., 
2005; Guédon et al., 2005; Belitsky and Sonenshein, 2008). However, the 
degenerate sequence AATTTTCWGAAAATT is not a reliable guide for 
identifying the actual CodY-binding motif in C. botulinum. Previous studies 
of CodY in B. subtilis suggested that CodY may effectively regulate target 
gene expression through interaction with sequences possessing up to five 
mismatches to the consensus motif (Belitsky and Sonenshein, 2008; Belitsky 
and Sonenshein, 2011). The sequence of Pntnh-botA contains several 
putative CodY-binding motifs with four or five mismatches to the consensus 
CodY-binding motif AATTTTCWGAAAATT. However, none of the putative 
CodY-binding motifs, except that present within the 30-bp region of Pntnh-
botA, were significantly recognized by CodY. These findings suggest that 
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CodY regulates botulinum neurotoxin gene expression mainly through the 
interaction with the 30-bp region in the promoter of the ntnh-botA operon. 
 
 
Figure 6 Schematic representation of transcriptional regulation of the neurotoxin gene in C. 
botulinum ATCC 3502. DNA-binding sites of BotR, CBO0786, and CodY are shown in orange, 
green, and blue respectively. 
An important transcriptional regulator of ntnh-botA operon is the 
alternative sigma factor BotR that specifically recognizes the core promoter 
of the ntnh-botA operon and directs the RNA polymerase core enzyme to 
transcribe ntnh and botA (Raffestin et al., 2005). The core promoter -10 
region of the ntnh-botA operon is located immediately upstream of the 30-bp 
CodY binding region (Figure 6), which raises the question of whether CodY 
interacts with BotR and/or the RNA polymerase core enzyme, thereby 
enhancing the transcription of the ntnh-botA operon. Furthermore, the core 
promoter -10 region of the ntnh-botA operon is also recognized by CBO0786, 
playing a repression role in the transcription of ntnh-botA operon (II, Figure 
6), which offers the possibility that CodY might interact with the CBO0786, 
thereby derepressing the transcription of the ntnh-botA operon. 
Interestingly, two putative CodY-binding motifs, AATTTTCAGtAgATa and 
AATTTTgTtAAAATa, each with three mismatches to the consensus CodY-
binding motif, were found upstream of the translation start site of cbo0787, 
implying that CodY might have a physiological role in regulating cbo0787 
expression. Further studies on the interaction of CodY with TCS 
CBO0787/CBO0786 may offer new insights into the regulatory mechanism 
of botulinum neurotoxin synthesis. 
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As a transition state regulator, CodY mediates the bacterial adaptation 
from nutrient-rich environment to nutrient-deficient environment by 
monitoring the intracellular level of GTP or BCAA, or both (Ratnayake-
Lecamwasam et al., 2001; Petranovic et al., 2004; Shivers and Sonenshein, 
2004). In C. botulinum ATCC 3502, GTP was found to enhance the DNA 
binding affinity for CodY to Pntnh-botA, suggesting that the CodY-mediated 
regulation of botulinum neurotoxin synthesis is associated with nutrition 
status.  
In C. difficile, CodY was found to be involved in pyruvate metabolism 
(Dineen et al., 2010) and  the addition of butyric acid or butanol to growth 
media significantly affected toxin production (Karlsson et al., 2000), 
suggesting a close relationship between fermentation pathways of butyrate 
and butanol-synthesis and toxin production. Whether pyruvate metabolism 
affects neurotoxin synthesis in C. botulinum remains completely unknown. 
Genome-wide characterization of the CodY regulon and functional analysis 
are required to understand the relationship between pyruvate metabolism 
and botulinum neurotoxin synthesis. 
6.4 Two-component signal transduction system (TCS) 
CBO0366/CBO0365 regulon genes involved in cold 
tolerance (IV) 
Comparative transcriptome analysis revealed that a large number of genes 
was regulated by TCS CBO0366/CBO0365. The direct transcriptional 
regulation of several genes encoding ABE fermentation pathway, phosphate 
transport, and arsenical resistance by response regulator CBO0365 was 
demonstrated by EMSA. 
During the obligate anaerobic growth of Clostridium strains, pyruvate 
derived from glycolysis is metabolized by multiple fermentation pathways 
and converted into a variety of fermentation end products, such as lactate, 
acetate, acetone, ethanol, butyrate, and butanol (Paredes et al., 2005; Janoir 
et al., 2013). Although the acetone-butanol-ethanol (ABE) fermentation 
pathway has not been studied in C. botulinum, the genome of C. botulinum 
ATCC 3502 harbors genes homologous to the components of ABE 
fermentation pathway in the solventogenic Clostridium acetobutylicum, 
suggesting a solvent-producing capability for group I C. botulinum (Sebaihia 
et al., 2007). We found that cbo1407 (bdh), cbo2847 (ctfA), cbo3199 (bcd), 
and cbo3202 (crt) are linked to cold tolerance in C. botulinum ATCC 3502. 
However, it remains unknown as to how the ABE fermentation pathway 
affects cold adaptation in C. botulinum ATCC 3502. One possibility could be 
that the genes of the ABE fermentation pathway might play a role in the 
biosynthesis of unsaturated fatty acids and branched-chain fatty acids, 
thereby increasing the membrane fluidity against the temperature downshift 
(Suutari and Laakso, 1994; Zhang and Rock, 2008). Interestingly, the global 
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regulator CodY plays an important regulatory role in both pyruvate 
metabolism and biosynthesis of branched-chain amino acids in several low-
G+C Gram-positive bacteria (Sonenshein, 2007). However, the pleiotropic 
functions of CodY in C. botulinum remain largely unknown except for the 
positive regulation of neurotoxin gene transcription (III). Further studies on 
the pleiotropic functions of CodY in pyruvate metabolism and amino acids 
biosynthesis in C. botulinum may offer new insights into cold adaptation 
mechanism, but also the possible links between cold adaptation and 
neurotoxin synthesis. 
We observed that cold tolerance is also related to other TCS 
CBO0366/CBO0365 regulon genes, such as phosphate ABC transporter gene 
cbo2525 (phoT)  and  arsenical resistance genes cbo0751 (arsC) and cbo0753 
(arsR). As a phosphate analogue, arsenate is able to be taken up by the 
phosphate transport system (Rosen and Liu, 2009). Although arsenical 
resistance is an important detoxifying mechanism and widely present in 
prokaryotes and eukaryotes (Stolz et al., 2006), arsenical resistance-related 
cold adaptation has not been reported. The molecular mechanism of 
arsenical resistance-related cold adaptation remains to be elucidated. 
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7. CONCLUSIONS 
1. Botulinum neurotoxin type E is encoded by large plasmids about 146 
kb in C. botulinum strains CB11/1-1, K51 and K22, supporting 
plasmid-mediated horizontal transfer of the neurotoxin type E gene. 
2. TCS CBO0787/CBO0786 negatively regulates botulinum neurotoxin 
gene expression in C. botulinum group I type A1 strain ATCC 3502. 
Response regulator CBO0786 inhibits the BotR-directed transcription 
from the ntnh-botA and ha promoters through a direct interaction 
with the conserved -10 site of the core promoters of the ntnh-botA and 
ha operons. 
3. CodY positively regulates botulinum neurotoxin gene expression 
through a direct interaction with a 30-bp region in the ntnh-botA 
promoter in C. botulinum Group I type A1 strain ATCC 3502. GTP can 
enhance the binding affinity of CodY to the ntnh-botA promoter, 
suggesting CodY-mediated neurotoxin regulation is associated with 
nutritional status. 
4. TCS CBO0366/CBO0365 regulates the expression of about 150 genes 
in C. botulinum ATCC 3502. CBO0365 regulon genes encoding the 
acetone-butanol-ethanol fermentation pathway, phosphate transport, 
and arsenical resistance are essential for cold tolerance of C. 
botulinum ATCC 3502.  
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